What Schools Are Affiliated With Peter Libby

Peter Libby is affiliated with the following schools: Uppsala University, University of Science and Technology of China, MD Anderson Cancer Center, Tufts University, McMaster University, Icahn School of Medicine at Mount Sinai, University of California, San Diego, Zhejiang University, University of California, San Francisco, Columbia University, Massachusetts General Hospital, Duke University, Washington University in St. Louis, McGill University, Yale University, University of Freiburg, University of British Columbia, Kobe University, Institute of Science Tokyo, Massachusetts Institute of Technology, University of Navarra, Shanghai Jiao Tong University, University of Texas Southwestern Medical Center, Harvard University

Peter Libby | Academic Influence

Peter Libby's AcademicInfluence.com Rankings

Peter Libby

Medical

#87

World Rank

#146

Historical Rank

#45

USA Rank

Cardiology

World Rank

Historical Rank

USA Rank

medical Degrees

Download Badge

Medical

Peter Libby's Degrees

Doctorate Medicine Columbia University
PhD Biochemistry Columbia University

Why Is Peter Libby Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Peter Libby is an American physician, focusing in atherosclerosis, cardiology and preventive cardiology, currently the Mallinckrodt Professor of Medicine, Harvard Medical School at Brigham and Women's Hospital.

(See a Problem?)

Peter Libby's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Inflammation in atherosclerosis (2002) (7839)
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease (2017) (5238)
Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. (2008) (4914)
Inflammation and Atherosclerosis (2002) (4911)
Progress and challenges in translating the biology of atherosclerosis (2011) (3271)
From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I. (2003) (2963)
Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. (2002) (2747)
Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. (1994) (2595)
Inflammation in Atherosclerosis (2012) (2353)
The immune response in atherosclerosis: a double-edged sword (2006) (2261)
Molecular bases of the acute coronary syndromes. (1995) (2102)
Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine, 2-Volume Set, 9th Edition Expert Consult Premium Edition €“ Enhanced Online Features (2011) (2064)
The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions (2007) (2033)
Identification of Splenic Reservoir Monocytes and Their Deployment to Inflammatory Sites (2009) (1975)
Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial. (2006) (1952)
Inflammation in atherosclerosis: from pathophysiology to practice. (2009) (1838)
Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. (1995) (1824)
Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. (1998) (1665)
Current Concepts of the Pathogenesis of the Acute Coronary Syndromes (2001) (1608)
Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease (2017) (1358)
Ly-6Chi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata. (2007) (1221)
From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II. (2003) (1200)
Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine, 2-Volume Set, 10th Edition (2011) (1190)
Innate and Adaptive Immunity in the Pathogenesis of Atherosclerosis (2002) (1058)
Inflammation and cardiovascular disease mechanisms. (2006) (1001)
Pathophysiology of Coronary Artery Disease (2005) (993)
Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial (2009) (989)
Reduction of atherosclerosis in mice by inhibition of CD40 signalling (1998) (968)
Inflammation in atherosclerosis: from vascular biology to biomarker discovery and risk prediction. (2008) (953)
Mechanisms of acute coronary syndromes and their implications for therapy. (2013) (933)
Local proliferation dominates lesional macrophage accumulation in atherosclerosis (2013) (890)
Myocardial infarction accelerates atherosclerosis (2012) (880)
Endothelial Cell Dysfunction and the Pathobiology of Atherosclerosis (2016) (867)
Obesity, inflammation, and atherosclerosis (2009) (831)
Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction. (2000) (807)
PDGF-dependent tyrosine phosphorylation stimulates production of novel polyphosphoinositides in intact cells (1989) (803)
The multifaceted contributions of leukocyte subsets to atherosclerosis: lessons from mouse models (2008) (800)
The CD40/CD154 receptor/ligand dyadRID="†"ID="†" Review (2001) (800)
Interleukin-1β inhibition and the prevention of recurrent cardiovascular events: rationale and design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS). (2011) (779)
Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for CD40-CD40 ligand signaling in atherosclerosis. (1997) (776)
An atherogenic diet rapidly induces VCAM-1, a cytokine-regulatable mononuclear leukocyte adhesion molecule, in rabbit aortic endothelium. (1993) (747)
Effect of two intensive statin regimens on progression of coronary disease. (2011) (744)
Effect of Antihypertensive Agents on Cardiovascular Events in Patients With Coronary Disease and Normal Blood Pressure The CAMELOT Study: A Randomized Controlled Trial (2004) (740)
Low‐Dose Methotrexate for the Prevention of Atherosclerotic Events (2019) (733)
Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial (2012) (729)
Therapeutic siRNA silencing in inflammatory monocytes (2011) (724)
Involvement of the immune system in human atherogenesis: current knowledge and unanswered questions. (1991) (720)
Deficiency and pharmacological stabilization of mast cells reduce diet-induced obesity and diabetes in mice (2009) (718)
Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial (2017) (713)
Atherosclerosis (2019) (712)
Cytokine-stimulated human vascular smooth muscle cells synthesize a complement of enzymes required for extracellular matrix digestion. (1994) (711)
Evidence for apoptosis in advanced human atheroma. Colocalization with interleukin-1 beta-converting enzyme. (1995) (706)
A randomized trial of rosuvastatin in the prevention of venous thromboembolism. (2009) (695)
Inflammation in atherosclerosis: transition from theory to practice. (2010) (691)
Induction and Stabilization of IκBα by Nitric Oxide Mediates Inhibition of NF-κB (*) (1995) (687)
Expression of the elastolytic cathepsins S and K in human atheroma and regulation of their production in smooth muscle cells. (1998) (685)
Macrophage myeloperoxidase regulation by granulocyte macrophage colony-stimulating factor in human atherosclerosis and implications in acute coronary syndromes. (2001) (685)
Evidence for increased collagenolysis by interstitial collagenases-1 and -3 in vulnerable human atheromatous plaques. (1999) (673)
Changing concepts of atherogenesis (2000) (659)
Cytokines and growth factors positively and negatively regulate interstitial collagen gene expression in human vascular smooth muscle cells. (1991) (637)
Peroxisome proliferator-activated receptor gamma activators inhibit gene expression and migration in human vascular smooth muscle cells. (1998) (630)
Activated Interstitial Myofibroblasts Express Catabolic Enzymes and Mediate Matrix Remodeling in Myxomatous Heart Valves (2001) (624)
An HMG-CoA Reductase Inhibitor, Cerivastatin, Suppresses Growth of Macrophages Expressing Matrix Metalloproteinases and Tissue Factor In Vivo and In Vitro (2001) (623)
Roles of infectious agents in atherosclerosis and restenosis: an assessment of the evidence and need for future research. (1997) (619)
The unstable atheroma. (1997) (615)
Inflammation and thrombosis: the clot thickens. (2001) (613)
Lipid lowering by diet reduces matrix metalloproteinase activity and increases collagen content of rabbit atheroma: a potential mechanism of lesion stabilization. (1998) (611)
Inflammation and atherosclerosis: role of C-reactive protein in risk assessment. (2004) (601)
Inflammatory mechanisms: the molecular basis of inflammation and disease. (2007) (599)
Chlamydial heat shock protein 60 localizes in human atheroma and regulates macrophage tumor necrosis factor-alpha and matrix metalloproteinase expression. (1998) (599)
Stabilization of atherosclerotic plaques: New mechanisms and clinical targets (2002) (595)
COVID-19 is, in the end, an endothelial disease (2020) (594)
Cutting Edge: Heat Shock Protein (HSP) 60 Activates the Innate Immune Response: CD14 Is an Essential Receptor for HSP60 Activation of Mononuclear Cells1 (2000) (593)
Immune effector mechanisms implicated in atherosclerosis: from mice to humans. (2013) (590)
Macrophage foam cells from experimental atheroma constitutively produce matrix-degrading proteinases. (1995) (583)
Cardiovascular remodelling in coronary artery disease and heart failure (2014) (580)
Noninvasive Vascular Cell Adhesion Molecule-1 Imaging Identifies Inflammatory Activation of Cells in Atherosclerosis (2006) (580)
Chlamydial and human heat shock protein 60s activate human vascular endothelium, smooth muscle cells, and macrophages. (1999) (576)
Macrophages Facilitate Electrical Conduction in the Heart (2017) (575)
CD40 Signaling and Plaque Instability (2001) (571)
PPARα Activators Inhibit Cytokine-Induced Vascular Cell Adhesion Molecule-1 Expression in Human Endothelial Cells (1999) (568)
Inflammation and cellular immune responses in abdominal aortic aneurysms. (2006) (566)
Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial (2017) (558)
Generation of Biologically Active IL-1β by Matrix Metalloproteinases: A Novel Caspase-1-Independent Pathway of IL-1β Processing (1998) (558)
Activation of monocyte/macrophage functions related to acute atheroma complication by ligation of CD40: induction of collagenase, stromelysin, and tissue factor. (1997) (558)
Interleukin 1 induces interleukin 1. I. Induction of circulating interleukin 1 in rabbits in vivo and in human mononuclear cells in vitro. (1987) (540)
Nanoparticle PET-CT Imaging of Macrophages in Inflammatory Atherosclerosis (2008) (536)
Host bone-marrow cells are a source of donor intimal smooth- muscle–like cells in murine aortic transplant arteriopathy (2001) (534)
Chronic variable stress activates hematopoietic stem cells (2014) (530)
Interleukin 1: a mitogen for human vascular smooth muscle cells that induces the release of growth-inhibitory prostanoids. (1988) (525)
A Cascade Model for Restenosis: A Special Case of Atherosclerosis Progression (1992) (521)
Angiotensin induces inflammatory activation of human vascular smooth muscle cells. (1999) (519)
Inflammation, Immunity, and HMG-CoA Reductase Inhibitors: Statins as Antiinflammatory Agents? (2004) (516)
Macrophages in Human Atheroma Contain PPARγ: Differentiation-Dependent Peroxisomal Proliferator-Activated Receptor γ (PPARγ) Expression and Reduction of MMP-9 Activity through PPARγ Activation in Mononuclear Phagocytes in Vitro (1998) (516)
Endotoxin and tumor necrosis factor induce interleukin-1 gene expression in adult human vascular endothelial cells. (1986) (513)
Macrophages and atherosclerotic plaque stability (1996) (507)
Expression of Interleukin (IL)-18 and Functional IL-18 Receptor on Human Vascular Endothelial Cells, Smooth Muscle Cells, and Macrophages (2002) (507)
Fatty acid modulation of endothelial activation. (2000) (501)
Differential expression of three T lymphocyte-activating CXC chemokines by human atheroma-associated cells. (1999) (497)
Soluble CD40L and Cardiovascular Risk in Women (2001) (491)
Cystatin C deficiency in human atherosclerosis and aortic aneurysms. (1999) (487)
Interferon-&ggr;, a Th1 Cytokine, Regulates Fat Inflammation: A Role for Adaptive Immunity in Obesity (2008) (479)
The omega-3 fatty acid docosahexaenoate reduces cytokine-induced expression of proatherogenic and proinflammatory proteins in human endothelial cells. (1994) (471)
Matrix metalloproteinase inhibition attenuates early left ventricular enlargement after experimental myocardial infarction in mice. (1999) (469)
Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trial. (2004) (459)
Rapid monocyte kinetics in acute myocardial infarction are sustained by extramedullary monocytopoiesis (2012) (453)
Metformin Inhibits Proinflammatory Responses and Nuclear Factor-&kgr;B in Human Vascular Wall Cells (2005) (445)
The changing landscape of atherosclerosis (2021) (440)
Adiponectin: a key adipocytokine in metabolic syndrome. (2006) (438)
Novel inflammatory markers of coronary risk: theory versus practice. (1999) (433)
Atherosclerosis and inflammation: overview and updates. (2018) (432)
Apoptosis of Vascular Smooth Muscle Cells Induced by In Vitro Stimulation With Interferon-γ, Tumor Necrosis Factor–α, and Interleukin-1β (1996) (430)
Extramedullary Hematopoiesis Generates Ly-6Chigh Monocytes That Infiltrate Atherosclerotic Lesions (2012) (426)
Mast cells promote atherosclerosis by releasing proinflammatory cytokines (2007) (424)
Ischemia and No Obstructive Coronary Artery Disease (INOCA): Developing Evidence-Based Therapies and Research Agenda for the Next Decade (2017) (421)
Ly-6Chigh Monocytes Depend on Nr4a1 to Balance Both Inflammatory and Reparative Phases in the Infarcted Myocardium (2014) (415)
Interleukin-1 Beta as a Target for Atherosclerosis Therapy: Biological Basis of CANTOS and Beyond. (2017) (411)
High-Dose Atorvastatin Enhances the Decline in Inflammatory Markers in Patients With Acute Coronary Syndromes in the MIRACL Study (2003) (410)
Inflammation and plaque vulnerability (2015) (409)
Soluble CD40L: Risk Prediction After Acute Coronary Syndromes (2003) (409)
Macrophage colony-stimulating factor gene expression in vascular cells and in experimental and human atherosclerosis. (1992) (408)
Inflammation in Atherosclerosis: Visualizing Matrix Metalloproteinase Action in Macrophages In Vivo (2006) (407)
Augmented expression of cyclooxygenase-2 in human atherosclerotic lesions. (1999) (404)
Role of inflammation in atherosclerosis associated with rheumatoid arthritis. (2008) (403)
A guiding map for inflammation (2017) (402)
Death of smooth muscle cells and expression of mediators of apoptosis by T lymphocytes in human abdominal aortic aneurysms. (1999) (401)
Statins Alter Smooth Muscle Cell Accumulation and Collagen Content in Established Atheroma of Watanabe Heritable Hyperlipidemic Rabbits (2001) (401)
Inflammation and its Resolution as Determinants of Acute Coronary Syndromes (2014) (398)
Cytokines Regulate Vascular Functions Related to Stability of the Atherosclerotic Plaque (1995) (398)
Generation of biologically active IL-1 beta by matrix metalloproteinases: a novel caspase-1-independent pathway of IL-1 beta processing. (1998) (389)
Lysosomal Cysteine Proteases in Atherosclerosis (2004) (388)
Endothelial function and coronary artery disease (2001) (387)
Coronary artery reperfusion. I. Early effects on local myocardial function and the extent of myocardial necrosis. (1972) (386)
Pravastatin has cholesterol-lowering independent effects on the artery wall of atherosclerotic monkeys. (1998) (386)
Inhibition of CD40 signaling limits evolution of established atherosclerosis in mice. (2000) (380)
Precordial S-T segment elevation mapping: an atraumatic method for assessing alterations in the extent of myocardial ischemic injury. The effects of pharmacologic and hemodynamic interventions. (1972) (377)
PPAR Activators as Antiinflammatory Mediators in Human T Lymphocytes: Implications for Atherosclerosis and Transplantation-Associated Arteriosclerosis (2002) (370)
Deficiency of cathepsin S reduces atherosclerosis in LDL receptor-deficient mice. (2003) (370)
Role of macrophage colony-stimulating factor in atherosclerosis: studies of osteopetrotic mice. (1997) (369)
Hypochlorous Acid, a Macrophage Product, Induces Endothelial Apoptosis and Tissue Factor Expression: Involvement of Myeloperoxidase-Mediated Oxidant in Plaque Erosion and Thrombogenesis (2004) (367)
Monocyte accumulation in mouse atherogenesis is progressive and proportional to extent of disease (2006) (367)
Rationale and design of the Cardiovascular Inflammation Reduction Trial: a test of the inflammatory hypothesis of atherothrombosis. (2013) (365)
Vascular biology of atherosclerosis: overview and state of the art. (2003) (363)
Proliferating or interleukin 1-activated human vascular smooth muscle cells secrete copious interleukin 6. (1990) (362)
PPARγ Activation in Human Endothelial Cells Increases Plasminogen Activator Inhibitor Type-1 Expression PPARγ as a Potential Mediator in Vascular Disease (1999) (361)
Expression of Neutrophil Collagenase (Matrix Metalloproteinase-8) in Human Atheroma: A Novel Collagenolytic Pathway Suggested by Transcriptional Profiling (2001) (358)
Regulation of matrix metalloproteinase expression in human vascular smooth muscle cells by T lymphocytes: a role for CD40 signaling in plaque rupture? (1997) (357)
The forgotten majority: unfinished business in cardiovascular risk reduction. (2005) (356)
Human vascular smooth muscle cells. Target for and source of tumor necrosis factor. (1989) (356)
Human coronary transplantation-associated arteriosclerosis. Evidence for a chronic immune reaction to activated graft endothelial cells. (1991) (350)
Effects of Interleukin-1&bgr; Inhibition With Canakinumab on Hemoglobin A1c, Lipids, C-Reactive Protein, Interleukin-6, and Fibrinogen: A Phase IIb Randomized, Placebo-Controlled Trial (2012) (346)
Platelet Expression Profiling and Clinical Validation of Myeloid-Related Protein-14 as a Novel Determinant of Cardiovascular Events (2006) (341)
The Aging Cardiovascular System: Understanding It at the Cellular and Clinical Levels. (2017) (339)
CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: report from the clinical practice discussion group. (2004) (333)
Evidence for altered balance between matrix metalloproteinases and their inhibitors in human aortic diseases. (1997) (332)
Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis. (2016) (331)
The stromal cell-derived factor-1 chemokine is a potent platelet agonist highly expressed in atherosclerotic plaques. (2000) (331)
Production of platelet-derived growth factor-like mitogen by smooth-muscle cells from human atheroma. (1988) (330)
Inflammation, Immunity, and Infection in Atherothrombosis: JACC Review Topic of the Week. (2018) (330)
Prostaglandin E2 Suppresses Chemokine Production in Human Macrophages through the EP4 Receptor* (2002) (327)
Heart Disease: A Textbook of Cardiovascular Medicine. 7th Edition (2004) (326)
Implantation of vascular grafts lined with genetically modified endothelial cells. (1989) (326)
Hypoxia but not inflammation augments glucose uptake in human macrophages: Implications for imaging atherosclerosis with 18fluorine-labeled 2-deoxy-D-glucose positron emission tomography. (2011) (321)
Effect of Glucose‐Insulin‐Potassium Infusion on Myocardial Infarction following Experimental Coronary Artery Occlusion (1972) (320)
Modulation of the interleukin-6 signalling pathway and incidence rates of atherosclerotic events and all-cause mortality: analyses from the Canakinumab Anti-Inflammatory Thrombosis Outcomes Study (CANTOS) (2018) (320)
Macrophage-Derived Matrix Vesicles: An Alternative Novel Mechanism for Microcalcification in Atherosclerotic Plaques (2013) (318)
Chlamydia pneumoniae as an emerging risk factor in cardiovascular disease. (2002) (317)
Adenovirus-mediated gene transfer into normal rabbit arteries results in prolonged vascular cell activation, inflammation, and neointimal hyperplasia. (1995) (316)
Progression of Atheroma: A Struggle Between Death and Procreation (2002) (310)
Impaired infarct healing in atherosclerotic mice with Ly-6C(hi) monocytosis. (2010) (309)
Anti-Inflammatory Therapy With Canakinumab for the Prevention of Hospitalization for Heart Failure (2019) (308)
Cardiovascular disease in patients with chronic inflammation: mechanisms underlying premature cardiovascular events in rheumatologic conditions. (2015) (302)
Atherosclerosis: the new view. (2002) (299)
Inflammation and Immunity in Diseases of the Arterial Tree: Players and Layers (2015) (299)
Adaptive immunity and atherosclerosis. (2010) (299)
Reduction of experimental myocardial infarct size by corticosteroid administration. (1973) (298)
Arterial and Aortic Valve Calcification Abolished by Elastolytic Cathepsin S Deficiency in Chronic Renal Disease (2009) (296)
IRF3 and Type I Interferons Fuel a Fatal Response to Myocardial Infarction (2017) (294)
Microscopic localization of active proteases by in situ zymography: detection of matrix metalloproteinase activity in vascular tissue (1995) (294)
Enhanced Expression of Vascular Matrix Metalloproteinases Induced In Vitro by Cytokines and in Regions of Human Atherosclerotic Lesions a (1994) (293)
Circumferential stress and matrix metalloproteinase 1 in human coronary atherosclerosis. Implications for plaque rupture. (1996) (291)
Fas is expressed in human atherosclerotic intima and promotes apoptosis of cytokine-primed human vascular smooth muscle cells. (1997) (289)
Sustained Activation of Vascular Cells and Leukocytes in the Rabbit Aorta After Balloon Injury (1993) (285)
Interferon-gamma deficiency prevents coronary arteriosclerosis but not myocardial rejection in transplanted mouse hearts. (1997) (281)
Circulating cell adhesion molecules are correlated with ultrasound-based assessment of carotid atherosclerosis. (1998) (280)
Peroxisome Proliferator-Activated Receptor-γ Activators Inhibit IFN-γ-Induced Expression of the T Cell-Active CXC Chemokines IP-10, Mig, and I-TAC in Human Endothelial Cells1 (2000) (279)
Intertwining of thrombosis and inflammation in atherosclerosis (2007) (276)
Atherosclerotic Vascular Disease Conference: Writing Group III: pathophysiology. (2004) (275)
Induction and stabilization of I kappa B alpha by nitric oxide mediates inhibition of NF-kappa B. (1995) (275)
Genesis and growth of extracellular vesicle-derived microcalcification in atherosclerotic plaques (2015) (274)
Report of the National Heart, Lung, and Blood Institute-National Institute of Diabetes and Digestive and Kidney Diseases Working Group on Cardiovascular Complications of Type 1 Diabetes Mellitus. (2005) (271)
Proliferation and Recruitment Contribute to Myocardial Macrophage Expansion in Chronic Heart Failure. (2016) (269)
Acute Coronary Syndromes: The Way Forward From Mechanisms to Precision Treatment (2017) (265)
The American Journal of Cardiology and Journal of Periodontology editors' consensus: periodontitis and atherosclerotic cardiovascular disease. (2009) (264)
Interleukin 1 induces interleukin 1. II. Recombinant human interleukin 1 induces interleukin 1 production by adult human vascular endothelial cells. (1987) (261)
Apolipoprotein CIII Induces Expression of Vascular Cell Adhesion Molecule-1 in Vascular Endothelial Cells and Increases Adhesion of Monocytic Cells (2006) (260)
Vascular remodeling in transplant vasculopathy. (2007) (260)
Self-renewing resident arterial macrophages arise from embryonic CX3CR1+ precursors and circulating monocytes immediately after birth (2015) (260)
Heterozygous osteopetrotic (op) mutation reduces atherosclerosis in LDL receptor- deficient mice. (1998) (259)
Leukocytes Link Local and Systemic Inflammation in Ischemic Cardiovascular Disease: An Expanded "Cardiovascular Continuum". (2016) (257)
TLR2 and neutrophils potentiate endothelial stress, apoptosis and detachment: implications for superficial erosion. (2015) (256)
Targeting inflammation in atherosclerosis — from experimental insights to the clinic (2021) (255)
Mast cells modulate the pathogenesis of elastase-induced abdominal aortic aneurysms in mice. (2007) (255)
Overexpression of Eotaxin and the CCR3 Receptor in Human Atherosclerosis: Using Genomic Technology to Identify a Potential Novel Pathway of Vascular Inflammation (2000) (255)
Optical Visualization of Cathepsin K Activity in Atherosclerosis With a Novel, Protease-Activatable Fluorescence Sensor (2007) (250)
Inducible interleukin-1 gene expression in human vascular smooth muscle cells. (1986) (248)
Atherosclerosis and proteinase activation. (2006) (248)
The vulnerable atherosclerotic plaque: pathogenesis and therapeutic approach. (2004) (248)
Requiem for the 'vulnerable plaque'. (2015) (247)
Macrophages in human atheroma contain PPARgamma: differentiation-dependent peroxisomal proliferator-activated receptor gamma(PPARgamma) expression and reduction of MMP-9 activity through PPARgamma activation in mononuclear phagocytes in vitro. (1998) (245)
Rationale and design of the Pemafibrate to Reduce Cardiovascular Outcomes by Reducing Triglycerides in Patients with Diabetes (PROMINENT) study (2018) (244)
The Nuclear Factor κ-B Signaling Pathway Participates in Dysregulation of Vascular Smooth Muscle Cells in Vitroand in Human Atherosclerosis* (1997) (242)
Coronary artery injury and the biology of atherosclerosis: inflammation, thrombosis, and stabilization. (2000) (241)
HMG CoA reductase inhibitors reduce plasminogen activator inhibitor-1 expression by human vascular smooth muscle and endothelial cells. (2000) (239)
The molecular mechanisms of the thrombotic complications of atherosclerosis (2008) (238)
Mucosal Administration of Heat Shock Protein-65 Decreases Atherosclerosis and Inflammation in Aortic Arch of Low-Density Lipoprotein Receptor-Deficient Mice (2002) (236)
Statins Reduce Inflammation in Atheroma of Nonhuman Primates Independent of Effects on Serum Cholesterol (2002) (235)
Leupeptin, a protease inhibitor, decreases protein degradation in normal and diseased muscles. (1978) (234)
Myeloid-Related Protein-8/14 Is Critical for the Biological Response to Vascular Injury (2009) (234)
Fish oil and postoperative atrial fibrillation: the Omega-3 Fatty Acids for Prevention of Post-operative Atrial Fibrillation (OPERA) randomized trial. (2012) (232)
Human interleukin 1 induces interleukin 1 gene expression in human vascular smooth muscle cells (1987) (231)
A fluorescent probe for the detection of myeloperoxidase activity in atherosclerosis-associated macrophages. (2007) (230)
Th2-predominant inflammation and blockade of IFN-gamma signaling induce aneurysms in allografted aortas. (2004) (228)
Matrix Metalloproteinase-13/Collagenase-3 Deletion Promotes Collagen Accumulation and Organization in Mouse Atherosclerotic Plaques (2005) (228)
CD40 Ligand Mediates Inflammation Independently of CD40 by Interaction With Mac-1 (2007) (226)
The American Journal of Cardiology and Journal of Periodontology Editors' Consensus: periodontitis and atherosclerotic cardiovascular disease. (2009) (226)
Tissue factor pathway inhibitor-2 is a novel inhibitor of matrix metalloproteinases with implications for atherosclerosis. (2001) (226)
Cathepsin L expression and regulation in human abdominal aortic aneurysm, atherosclerosis, and vascular cells. (2006) (223)
Inflammatory Cytokines and Oxidized Low Density Lipoproteins Increase Endothelial Cell Expression of Membrane Type 1-Matrix Metalloproteinase* (1999) (222)
Endothelin-1 and endothelin receptor mRNA expression in normal and atherosclerotic human arteries. (1993) (221)
Inducible expression of vascular cell adhesion molecule-1 by vascular smooth muscle cells in vitro and within rabbit atheroma. (1993) (221)
Deficiency of the Cysteine Protease Cathepsin S Impairs Microvessel Growth (2003) (220)
Sleep modulates hematopoiesis and protects against atherosclerosis (2018) (218)
Spatiotemporal controlled delivery of nanoparticles to injured vasculature (2010) (218)
In vivo silencing of the transcription factor IRF5 reprograms the macrophage phenotype and improves infarct healing. (2013) (218)
Neutrophil Elastase in Human Atherosclerotic Plaques: Production by Macrophages (2003) (217)
18F-4V for PET-CT imaging of VCAM-1 expression in atherosclerosis. (2009) (217)
Mechanisms of plaque stabilization with statins. (2003) (216)
Culture of quiescent arterial smooth muscle cells in a defined serum‐free medium (1983) (215)
Elevated Plasma Levels of the Atherogenic Mediator Soluble CD40 Ligand in Diabetic Patients: A Novel Target of Thiazolidinediones (2003) (214)
Inducible expression of class II major histocompatibility complex antigens and the immunogenicity of vascular endothelium. (1986) (211)
Atherosclerosis: Successes, Surprises, and Future Challenges. (2016) (209)
Lipid Lowering Reduces Oxidative Stress and Endothelial Cell Activation in Rabbit Atheroma (2002) (209)
Anti-Inflammatory Therapy With Canakinumab for the Prevention and Management of Diabetes. (2018) (209)
What have we learned about the biology of atherosclerosis? The role of inflammation. (2001) (207)
COVID-19 – A vascular disease (2020) (207)
Expression of monocyte chemotactic protein and interleukin-8 by cytokine-activated human vascular smooth muscle cells. (1991) (206)
Neutrophil extracellular traps form predominantly during the organizing stage of human venous thromboembolism development (2014) (204)
T lymphocytes induce endothelial cell matrix metalloproteinase expression by a CD40L-dependent mechanism: implications for tubule formation. (1999) (203)
CD40 signaling in vascular cells: a key role in atherosclerosis? (1998) (202)
Cytokines and growth factors in atherogenesis. (1992) (202)
Molecular imaging of cardiovascular disease. (2007) (202)
Reassessing the Mechanisms of Acute Coronary Syndromes: The “Vulnerable Plaque” and Superficial Erosion (2019) (201)
Adiponectin Inhibits the Production of CXC Receptor 3 Chemokine Ligands in Macrophages and Reduces T-Lymphocyte Recruitment in Atherogenesis (2008) (201)
Distinct patterns of expression of fibroblast growth factors and their receptors in human atheroma and nonatherosclerotic arteries. Association of acidic FGF with plaque microvessels and macrophages. (1993) (200)
27th Bethesda Conference: matching the intensity of risk factor management with the hazard for coronary disease events. Task Force 1. Pathogenesis of coronary disease: the biologic role of risk factors. (1996) (196)
PPARalpha activators inhibit cytokine-induced vascular cell adhesion molecule-1 expression in human endothelial cells. (1999) (196)
Differential Expression of the IFN-γ-Inducible CXCR3-Binding Chemokines, IFN-Inducible Protein 10, Monokine Induced by IFN, and IFN-Inducible T Cell α Chemoattractant in Human Cardiac Allografts: Association with Cardiac Allograft Vasculopathy and Acute Rejection1 (2002) (195)
Inflammation and Atherothrombosis: From Population Biology and Bench Research to Clinical Practice (2006) (195)
Mechanical Strain Induces Specific Changes in the Synthesis and Organization of Proteoglycans by Vascular Smooth Muscle Cells* (2001) (195)
Molecular and cellular imaging of atherosclerosis: emerging applications. (2006) (194)
Selective Matrix Metalloproteinase Inhibition Reduces Left Ventricular Remodeling but Does Not Inhibit Angiogenesis After Myocardial Infarction (2002) (193)
Real-Time Catheter Molecular Sensing of Inflammation in Proteolytically Active Atherosclerosis (2008) (192)
Hyperlipidemia and atherosclerotic lesion development in LDL receptor-deficient mice fed defined semipurified diets with and without cholate. (1999) (192)
HDL cholesterol and residual risk of first cardiovascular events after treatment with potent statin therapy: an analysis from the JUPITER trial (2010) (191)
Nitric Oxide Inhibits Macrophage-Colony Stimulating Factor Gene Transcription in Vascular Endothelial Cells (*) (1995) (191)
Braunwald's heart disease (2015) (190)
Cathepsin L-selective inhibitors: A potentially promising treatment for COVID-19 patients (2020) (186)
Oxidized Low-Density Lipoprotein Augments and 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors Limit CD40 and CD40L Expression in Human Vascular Cells (2002) (186)
Regulation of smooth muscle cell scavenger receptor expression in vivo by atherogenic diets and in vitro by cytokines. (1995) (186)
Optical and Multimodality Molecular Imaging: Insights Into Atherosclerosis (2009) (185)
Effects of Intraaortic Balloon Counterpulsation on the Severity of Myocardial Ischemic Injury following Acute Coronary Occlusion: Counterpulsation and Myocardial Injury (1972) (185)
Activatable Magnetic Resonance Imaging Agent Reports Myeloperoxidase Activity in Healing Infarcts and Noninvasively Detects the Antiinflammatory Effects of Atorvastatin on Ischemia-Reperfusion Injury (2008) (185)
Apolipoprotein CIII in Apolipoprotein B Lipoproteins Enhances the Adhesion of Human Monocytic Cells to Endothelial Cells (2006) (185)
Adiponectin deficiency increases allergic airway inflammation and pulmonary vascular remodeling. (2009) (183)
TH2 Predominant Immune Responses Prevail in Human Abdominal Aortic Aneurysm (2002) (183)
Genetic Interleukin 6 Signaling Deficiency Attenuates Cardiovascular Risk in Clonal Hematopoiesis (2019) (183)
Functions of vascular wall cells related to development of transplantation-associated coronary arteriosclerosis. (1989) (182)
Effect of Atorvastatin on Risk of Recurrent Cardiovascular Events After an Acute Coronary Syndrome Associated With High Soluble CD40 Ligand in the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study (2004) (180)
Sortilin mediates vascular calcification via its recruitment into extracellular vesicles. (2016) (177)
Indocyanine Green Enables Near-Infrared Fluorescence Imaging of Lipid-Rich, Inflamed Atherosclerotic Plaques (2011) (177)
Neutrophil Extracellular Traps Induce Endothelial Cell Activation and Tissue Factor Production Through Interleukin-1&agr; and Cathepsin G (2018) (176)
Genetically programmed biases in Th1 and Th2 immune responses modulate atherogenesis. (2008) (175)
Macrophage Migration Inhibitory Factor Deficiency Impairs Atherosclerosis in Low-Density Lipoprotein Receptor–Deficient Mice (2004) (174)
C-reactive protein induces matrix metalloproteinase-1 and -10 in human endothelial cells: implications for clinical and subclinical atherosclerosis. (2006) (173)
Dietary lipid lowering reduces tissue factor expression in rabbit atheroma. (1999) (172)
Apoptosis of vascular smooth muscle cells induced by in vitro stimulation with interferon-gamma, tumor necrosis factor-alpha, and interleukin-1 beta. (1996) (172)
More than an anticoagulant: Do heparins have direct anti-inflammatory effects? (2016) (171)
Reduction by Hyaluronidase of Myocardial Necrosis following Coronary Artery Occlusion (1972) (170)
Targeting Interleukin-1&bgr; Reduces Leukocyte Production After Acute Myocardial Infarction (2015) (170)
Cytokine induction by lipopolysaccharide (LPS) corresponds to lethal toxicity and is inhibited by nontoxic Rhodobacter capsulatus LPS (1990) (168)
Host CD40 Ligand Deficiency Induces Long-Term Allograft Survival and Donor-Specific Tolerance in Mouse Cardiac Transplantation But Does Not Prevent Graft Arteriosclerosis1 (2000) (167)
Myocardial Infarction Activates CCR2(+) Hematopoietic Stem and Progenitor Cells. (2015) (167)
Expression of Stromelysin-3 in Atherosclerotic Lesions: Regulation via CD40–CD40 Ligand Signaling In Vitro and In Vivo (1999) (167)
High-Resolution Magnetic Resonance Imaging Enhanced With Superparamagnetic Nanoparticles Measures Macrophage Burden in Atherosclerosis (2010) (166)
Myeloid-related protein 8/14 and the risk of cardiovascular death or myocardial infarction after an acute coronary syndrome in the Pravastatin or Atorvastatin Evaluation and Infection Therapy: Thrombolysis in Myocardial Infarction (PROVE IT-TIMI 22) trial. (2008) (166)
Cytokines in the Pathogenesis of Atherosclerosis (2002) (165)
CD40 ligation induces tissue factor expression in human vascular smooth muscle cells. (2000) (165)
PPAR&agr; Activators Inhibit Tissue Factor Expression and Activity in Human Monocytes (2001) (164)
Interleukins in cancer: from biology to therapy (2021) (164)
Emerging Mechanisms of Cardiovascular Protection for the Omega-3 Fatty Acid Eicosapentaenoic Acid (2020) (161)
Mechanical strain tightly controls fibroblast growth factor-2 release from cultured human vascular smooth muscle cells. (1997) (160)
Cathepsin L activity controls adipogenesis and glucose tolerance (2007) (160)
Favorable effects of hyaluronidase on electrocardiographic evidence of necrosis in patients with acute myocardial infarction. (1977) (160)
Nitric Oxide Attenuates Vascular Smooth Muscle Cell Activation by Interferon- (1996) (159)
Cardiovascular drug development: is it dead or just hibernating? (2015) (159)
The Vascular Biology of Atherosclerosis and Imaging Targets (2010) (158)
Roles of PAD4 and NETosis in Experimental Atherosclerosis and Arterial Injury: Implications for Superficial Erosion (2018) (157)
Clonal haematopoiesis: connecting ageing and inflammation in cardiovascular disease (2019) (157)
Augmented Expression and Activity of Extracellular Matrix-Degrading Enzymes in Regions of Low Endothelial Shear Stress Colocalize With Coronary Atheromata With Thin Fibrous Caps in Pigs (2011) (157)
Free Cholesterol Accumulation in Macrophage Membranes Activates Toll-Like Receptors and p38 Mitogen-Activated Protein Kinase and Induces Cathepsin K (2009) (156)
Lipid lowering promotes accumulation of mature smooth muscle cells expressing smooth muscle myosin heavy chain isoforms in rabbit atheroma. (1998) (156)
Cystatin C Deficiency Increases Elastic Lamina Degradation and Aortic Dilatation in Apolipoprotein E–Null Mice (2005) (155)
Atherosclerosis: disease biology affecting the coronary vasculature. (2006) (155)
IgE stimulates human and mouse arterial cell apoptosis and cytokine expression and promotes atherogenesis in Apoe-/- mice. (2011) (154)
The Serpin Proteinase Inhibitor 9 Is an Endogenous Inhibitor of Interleukin 1β–Converting Enzyme (Caspase-1) Activity in Human Vascular Smooth Muscle Cells (2000) (154)
Two-dimensional intravascular near-infrared fluorescence molecular imaging of inflammation in atherosclerosis and stent-induced vascular injury. (2011) (153)
Relation of baseline high-sensitivity C-reactive protein level to cardiovascular outcomes with rosuvastatin in the Justification for Use of statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER). (2010) (150)
Thrombin promotes activation of matrix metalloproteinase-2 produced by cultured vascular smooth muscle cells. (1997) (149)
B7-1/B7-2 Costimulation Regulates Plaque Antigen–Specific T-Cell Responses and Atherogenesis in Low-Density Lipoprotein Receptor–Deficient Mice (2004) (149)
Transcriptional profile of mechanically induced genes in human vascular smooth muscle cells. (1999) (148)
Polymeric Nanoparticle PET/MR Imaging Allows Macrophage Detection in Atherosclerotic Plaques (2013) (147)
Induction of Tissue Factor Expression in Human Endothelial Cells by CD40 Ligand Is Mediated via Activator Protein 1, Nuclear Factor κB, and Egr-1* (2002) (147)
RNAi targeting multiple cell adhesion molecules reduces immune cell recruitment and vascular inflammation after myocardial infarction (2016) (146)
CD1 expression in human atherosclerosis. A potential mechanism for T cell activation by foam cells. (1999) (146)
Adult human vascular endothelial cells express the IL6 gene differentially in response to LPS or IL1. (1989) (146)
The AIM2 inflammasome exacerbates atherosclerosis in clonal haematopoiesis (2021) (145)
Inhibition of Interleukin-1β by Canakinumab and Cardiovascular Outcomes in Patients With Chronic Kidney Disease. (2018) (144)
Diabetic macrovascular disease: the glucose paradox? (2002) (144)
PPARgamma activation in human endothelial cells increases plasminogen activator inhibitor type-1 expression: PPARgamma as a potential mediator in vascular disease. (1999) (144)
IL-6 inhibition with ziltivekimab in patients at high atherosclerotic risk (RESCUE): a double-blind, randomised, placebo-controlled, phase 2 trial (2021) (143)
Long-term effects of maximally intensive statin therapy on changes in coronary atheroma composition: insights from SATURN. (2014) (143)
Inhibition of Atherogenesis in BLT1-Deficient Mice Reveals a Role for LTB4 and BLT1 in Smooth Muscle Cell Recruitment (2005) (141)
Elastogenesis in Human Arterial Disease: A Role for Macrophages in Disordered Elastin Synthesis (2003) (141)
The molecular bases of restenosis. (1997) (140)
Macrophages retain hematopoietic stem cells in the spleen via VCAM-1 (2015) (140)
Critical Role of Mast Cell Chymase in Mouse Abdominal Aortic Aneurysm Formation (2009) (138)
The infarcted myocardium solicits GM-CSF for the detrimental oversupply of inflammatory leukocytes (2017) (138)
Current concepts in cardiovascular pathology: the role of LDL cholesterol in plaque rupture and stabilization. (1998) (137)
Adiponectin Inhibits Pro-inflammatory Signaling in Human Macrophages Independent of Interleukin-10* (2009) (136)
Proliferating arterial smooth muscle cells after balloon injury express TNF-alpha but not interleukin-1 or basic fibroblast growth factor. (1996) (135)
Inflammation and Atherothrombosis (2001) (133)
Thoughts on the role of the healing professions and the events of September 11, 2001. (2002) (133)
Characterization of Human Atherosclerotic Plaques by Intravascular Magnetic Resonance Imaging (2005) (133)
Potential infectious etiologies of atherosclerosis: a multifactorial perspective. (2001) (132)
Cathepsin L Deficiency Reduces Diet-Induced Atherosclerosis in Low-Density Lipoprotein Receptor-Knockout Mice (2007) (131)
Baseline characteristics of participants in the JUPITER trial, a randomized placebo-controlled primary prevention trial of statin therapy among individuals with low low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein. (2007) (130)
Vascular Biomarkers and Surrogates in Cardiovascular Disease (2006) (129)
Ligation of CD40 Activates Interleukin 1β-converting Enzyme (Caspase-1) Activity in Vascular Smooth Muscle and Endothelial Cells and Promotes Elaboration of Active Interleukin 1β* (1997) (129)
Exercise reduces inflammatory cell production and cardiovascular inflammation via instruction of hematopoietic progenitor cells (2019) (129)
Mechanical deformation promotes secretion of IL-1 alpha and IL-1 receptor antagonist. (1997) (129)
Flow Perturbation Mediates Neutrophil Recruitment and Potentiates Endothelial Injury via TLR2 in Mice: Implications for Superficial Erosion (2017) (128)
Expression of tissue inhibitor of metalloproteinases-3 in human atheroma and regulation in lesion-associated cells: a potential protective mechanism in plaque stability. (1998) (127)
Plaque erosion: a new in vivo diagnosis and a potential major shift in the management of patients with acute coronary syndromes. (2018) (126)
T(H)2 predominant immune responses prevail in human abdominal aortic aneurysm. (2002) (125)
Vascular endothelium and atherosclerosis. (2006) (125)
Increased apolipoprotein E and c-fms gene expression without elevated interleukin 1 or 6 mRNA levels indicates selective activation of macrophage functions in advanced human atheroma. (1992) (125)
Residual inflammatory risk associated with interleukin-18 and interleukin-6 after successful interleukin-1β inhibition with canakinumab: further rationale for the development of targeted anti-cytokine therapies for the treatment of atherothrombosis. (2020) (124)
Immune interferon inhibits proliferation and induces 2'-5'-oligoadenylate synthetase gene expression in human vascular smooth muscle cells. (1989) (124)
Rationale, design, and governance of Prospective Randomized Evaluation of Celecoxib Integrated Safety versus Ibuprofen Or Naproxen (PRECISION), a cardiovascular end point trial of nonsteroidal antiinflammatory agents in patients with arthritis. (2009) (123)
Thrombin potently stimulates cytokine production in human vascular smooth muscle cells but not in mononuclear phagocytes. (1996) (123)
Interleukin-18, the Metabolic Syndrome, and Subclinical Atherosclerosis: Results From the Dallas Heart Study (2007) (123)
CD154 (CD40 ligand). (2000) (122)
Matrix Metalloproteinase-14 Deficiency in Bone Marrow–Derived Cells Promotes Collagen Accumulation in Mouse Atherosclerotic Plaques (2008) (122)
Inflamm-ageing: the role of inflammation in age-dependent cardiovascular disease. (2020) (122)
Temporal shifts in clinical presentation and underlying mechanisms of atherosclerotic disease (2017) (122)
Plasma concentrations of interleukin-6 and abdominal aortic diameter among subjects without aortic dilatation. (1999) (121)
Moderate Hypoxia Potentiates Interleukin-1&bgr; Production in Activated Human Macrophages (2014) (120)
The inflammation hypothesis and its potential relevance to statin therapy. (2007) (120)
Inflammation in Diabetes Mellitus: Role of Peroxisome Proliferator-Activated Receptor–α and Peroxisome Proliferator-Activated Receptor–γ Agonists (2007) (117)
From Focal Lipid Storage to Systemic Inflammation: JACC Review Topic of the Week. (2019) (116)
Non-coronary atherosclerosis. (2014) (116)
Innate Response Activator B Cells Aggravate Atherosclerosis by Stimulating T Helper-1 Adaptive Immunity (2014) (115)
Omega-3 fatty acids and endothelial leukocyte adhesion molecules. (1995) (114)
Cholesterol and atherosclerosis. (2000) (113)
Clonal Hematopoiesis: Crossroads of Aging, Cardiovascular Disease, and Cancer: JACC Review Topic of the Week. (2019) (113)
Molecular imaging of atherosclerosis for improving diagnostic and therapeutic development. (2012) (112)
MRI of rabbit atherosclerosis in response to dietary cholesterol lowering. (1999) (111)
Caspase-3-induced gelsolin fragmentation contributes to actin cytoskeletal collapse, nucleolysis, and apoptosis of vascular smooth muscle cells exposed to proinflammatory cytokines. (1998) (111)
Cysteine protease cathepsins in cardiovascular disease: from basic research to clinical trials (2018) (111)
Biomechanical Strain Induces Class A Scavenger Receptor Expression in Human Monocyte/Macrophages and THP-1 Cells: A Potential Mechanism of Increased Atherosclerosis in Hypertension (2001) (110)
Direct Anti-Inflammatory Mechanisms Contribute to Attenuation of Experimental Allograft Arteriosclerosis by Statins (2003) (110)
C-Reactive Protein, but not Low-Density Lipoprotein Cholesterol Levels, Associate With Coronary Atheroma Regression and Cardiovascular Events After Maximally Intensive Statin Therapy (2013) (109)
Mechanisms of erosion of atherosclerotic plaques. (2017) (109)
Structural requirements for inhibition of cytokine-induced endothelial activation by unsaturated fatty acids. (1998) (108)
Noninvasive In Vivo Imaging of Monocyte Trafficking to Atherosclerotic Lesions (2008) (108)
Deletion of the phosphoinositide 3-kinase p110γ gene attenuates murine atherosclerosis (2007) (108)
Leptin Deficiency Shifts Mast Cells toward Anti-Inflammatory Actions and Protects Mice from Obesity and Diabetes by Polarizing M2 Macrophages. (2015) (106)
Adiponectin Induces Pro-inflammatory Programs in Human Macrophages and CD4+ T Cells (2012) (105)
Innate and adaptive immunity in atherosclerosis (2009) (105)
Control of endothelial leukocyte adhesion molecules by fatty acids (2007) (105)
Selective Inhibition of Matrix Metalloproteinase-13 Increases Collagen Content of Established Mouse Atherosclerosis (2011) (104)
Binding of CD40L to Mac-1's I-Domain Involves the EQLKKSKTL Motif and Mediates Leukocyte Recruitment and Atherosclerosis—But Does Not Affect Immunity and Thrombosis in Mice (2011) (104)
Non-invasive anatomic and functional imaging of vascular inflammation and unstable plaque. (2012) (103)
Coronary arteriosclerosis after T-cell-mediated injury in transplanted mouse hearts: role of interferon-gamma. (1998) (102)
Inflammation in Atherosclerosis-No Longer a Theory. (2020) (102)
Human vascular smooth muscle cell-monocyte interactions and metalloproteinase secretion in culture. (1995) (102)
The pathogenesis of coronary arteriosclerosis ("chronic rejection") in transplanted hearts. (1994) (101)
Increased glucose uptake in visceral versus subcutaneous adipose tissue revealed by PET imaging. (2009) (100)
Gut intraepithelial T cells calibrate metabolism and accelerate cardiovascular disease (2018) (100)
Associations Between Soluble CD40 Ligand, Atherosclerosis Risk Factors, and Subclinical Atherosclerosis: Results from the Dallas Heart Study (2005) (100)
Highlights of 10 years of immunology in Nature Reviews Immunology (2011) (99)
Effect of practolol on the extent of myocardial ischaemic injury after experimental coronary occlusion and its effects of ventricular function in the normal and ischaemic heart. (1973) (99)
IL-2 rapidly induces natural killer cell adhesion to human endothelial cells. A potential mechanism for endothelial injury. (1988) (99)
Peroxisome proliferator-activated receptor-gamma activators inhibit IFN-gamma-induced expression of the T cell-active CXC chemokines IP-10, Mig, and I-TAC in human endothelial cells. (2000) (99)
Essential Role for Smad3 in Regulating MCP-1 Expression and Vascular Inflammation (2004) (97)
Cathepsin K Deficiency Reduces Elastase Perfusion–Induced Abdominal Aortic Aneurysms in Mice (2012) (97)
CD11c+ Dendritic Cells Maintain Antigen Processing, Presentation Capabilities, and CD4+ T-Cell Priming Efficacy Under Hypercholesterolemic Conditions Associated With Atherosclerosis (2008) (97)
Effects of Interleukin-1 Inhibition With Canakinumab on Hemoglobin A 1 c , Lipids , C-Reactive Protein , Interleukin-6 , and Fibrinogen A Phase IIb Randomized , Placebo-Controlled Trial (2012) (97)
Characterization of smooth muscle-like cells in circulating human peripheral blood. (2006) (96)
The neutrophil-lymphocyte ratio and incident atherosclerotic events: analyses from five contemporary randomized trials. (2021) (96)
Prostaglandin E Receptor Type 4-associated Protein Interacts Directly with NF-κB1 and Attenuates Macrophage Activation* (2008) (95)
Atherogenic lipids, vascular dysfunction, and clinical signs of ischemic heart disease. (1997) (94)
The role of macrophages in atherogenesis (1993) (94)
Regulation of matrix metalloproteinases and plasminogen activator inhibitor-1 synthesis by plasminogen in cultured human vascular smooth muscle cells. (1996) (94)
Functional significance of human vascular smooth muscle cell-derived interleukin 1 in paracrine and autocrine regulation pathways. (1992) (93)
Interleukin-1 gene expression in rabbit vascular tissue in vivo. (1991) (93)
Degradation of the acetylcholine receptor in cultured muscle cells: Selective inhibitors and the fate of undegraded receptors (1980) (93)
Silencing of CCR2 in myocarditis. (2015) (92)
The interface of atherosclerosis and thrombosis: basic mechanisms (1998) (92)
Regulation of Major Histocompatibility Gene Expression in Human Vascular Smooth Muscle Cells (1989) (91)
Soluble CD40 Ligand Levels Indicate Lipid Accumulation in Carotid Atheroma: An In Vivo Study With High-Resolution MRI (2003) (91)
A neuraminidase from Trypanosoma cruzi removes sialic acid from the surface of mammalian myocardial and endothelial cells. (1986) (91)
Effects of hyaluronidase administration on myocardial ischemic injury in acute infarction. A preliminary study in 24 patients. (1975) (91)
Atherogenic diets enhance endotoxin-stimulated interleukin-1 and tumor necrosis factor gene expression in rabbit aortae. (1992) (90)
Genetically Determined Resistance to Collagenase Action Augments Interstitial Collagen Accumulation in Atherosclerotic Plaques (2004) (90)
The Risk of Major NSAID Toxicity with Celecoxib, Ibuprofen, or Naproxen: A Secondary Analysis of the PRECISION Trial. (2017) (90)
Coronary atheroma volume and cardiovascular events during maximally intensive statin therapy. (2013) (89)
Molecular Determinants of Atherosclerotic Plaque Vulnerability a (1997) (89)
Vascular cell adhesion molecule-1 and smooth muscle cell activation during atherogenesis. (1993) (88)
Adult human endothelial cell coverage of small-caliber Dacron and polytetrafluoroethylene vascular prostheses in vitro. (1986) (88)
Clinical implications of inflammation for cardiovascular primary prevention. (2010) (88)
Managing the risk of atherosclerosis: the role of high-density lipoprotein. (2001) (88)
Collagenases and cracks in the plaque. (2013) (87)
Apolipoprotein CIII–Induced THP-1 Cell Adhesion to Endothelial Cells Involves Pertussis Toxin–Sensitive G Protein– and Protein Kinase C&agr;–Mediated Nuclear Factor-&kgr;B Activation (2007) (87)
Relationship of oxidized phospholipids and biomarkers of oxidized low-density lipoprotein with cardiovascular risk factors, inflammatory biomarkers, and effect of statin therapy in patients with acute coronary syndromes: Results from the MIRACL (Myocardial Ischemia Reduction With Aggressive Choleste (2009) (87)
Act local, act global: inflammation and the multiplicity of "vulnerable" coronary plaques. (2005) (86)
TRAF-1, -2, -3, -5, and -6 Are Induced in Atherosclerotic Plaques and Differentially Mediate Proinflammatory Functions of CD40L in Endothelial Cells (2007) (86)
Lipoproteins increase growth of mitogen‐stimulated arterial smooth muscle cells (1985) (86)
Deficiency of antigen-presenting cell invariant chain reduces atherosclerosis in mice. (2009) (86)
C-Peptide Colocalizes with Macrophages in Early Arteriosclerotic Lesions of Diabetic Subjects and Induces Monocyte Chemotaxis In Vitro (2004) (85)
The selective peroxisome proliferator-activated receptor alpha modulator (SPPARMα) paradigm: conceptual framework and therapeutic potential (2019) (84)
Novel Antiatherosclerotic Therapies. (2019) (84)
Thin-Capped Atheromata With Reduced Collagen Content in Pigs Develop in Coronary Arterial Regions Exposed to Persistently Low Endothelial Shear Stress (2013) (84)
Kruppel-like Factor KLF10 Targets Transforming Growth Factor-β1 to Regulate CD4+CD25− T Cells and T Regulatory Cells* (2009) (84)
’ Consensus : Periodontitis and Atherosclerotic Cardiovascular Disease † (2009) (82)
The Heart in COVID19: Primary Target or Secondary Bystander? (2020) (81)
Interleukin-10 (IL-10) augments allograft arterial disease: paradoxical effects of IL-10 in vivo. (1999) (81)
Inflammation: a common contributor to cancer, aging, and cardiovascular diseases—expanding the concept of cardio-oncology (2019) (80)
Identifying patients at high risk of a cardiovascular event in the near future: current status and future directions: report of a national heart, lung, and blood institute working group. (2010) (80)
Imaging Macrophage and Hematopoietic Progenitor Proliferation in Atherosclerosis. (2015) (80)
Molecular biology of atherosclerosis. (1997) (80)
Inflammation, the endothelium, and the acute coronary syndromes. (1998) (80)
Angiotensin Type 2 Receptor Is Expressed in Murine Atherosclerotic Lesions and Modulates Lesion Evolution (2005) (79)
Diversity of denizens of the atherosclerotic plaque: not all monocytes are created equal. (2008) (79)
Inflammatory Biomarkers, Death, and Recurrent Nonfatal Coronary Events After an Acute Coronary Syndrome in the MIRACL Study (2013) (79)
Monocyte heterogeneity in cardiovascular disease (2013) (79)
Small Mechanical Strains Selectively Suppress Matrix Metalloproteinase-1 Expression by Human Vascular Smooth Muscle Cells* (1998) (79)
Comprar Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine, 2-Volume Set, 9th Edition Expert Consult Premium Edition €“ Enhanced Online Features | Peter Libby | 9781437727081 | Saunders (2011) (79)
Molecular Imaging of Innate Immune Cell Function in Transplant Rejection (2009) (78)
Stage-dependent differential effects of interleukin-1 isoforms on experimental atherosclerosis. (2019) (78)
Chronic rejection. (2001) (77)
Neutrophil Extracellular Traps Participate in Cardiovascular Diseases (2020) (77)
Ferritinophagy and ferroptosis in the management of metabolic diseases (2021) (77)
Increased Plasma Oxidized Phospholipid:Apolipoprotein B-100 Ratio With Concomitant Depletion of Oxidized Phospholipids From Atherosclerotic Lesions After Dietary Lipid-Lowering: A Potential Biomarker of Early Atherosclerosis Regression (2007) (77)
Tissue-Specific Macrophage Responses to Remote Injury Impact the Outcome of Subsequent Local Immune Challenge. (2019) (77)
Atheroma: more than mush (1996) (77)
Increased Microvascularization and Vessel Permeability Associate With Active Inflammation in Human Atheromata (2014) (76)
Mast Cell Tryptase Deficiency Attenuates Mouse Abdominal Aortic Aneurysm Formation (2011) (76)
Plaque stabilization: Can we turn theory into evidence? (2006) (75)
Cathepsin L Activity Is Essential to Elastase Perfusion–Induced Abdominal Aortic Aneurysms in Mice (2011) (74)
Epigenetics and precision medicine in cardiovascular patients: from basic concepts to the clinical arena (2018) (74)
Toll-Like Receptor 2 Mediates Apolipoprotein CIII–Induced Monocyte Activation: Retracted (2008) (74)
Human vascular smooth muscle cells poorly co-stimulate and actively inhibit allogeneic CD4+ T cell proliferation in vitro. (1995) (74)
Comparison between adventitial and intimal inflammation of ruptured and nonruptured atherosclerotic plaques in human coronary arteries. (2002) (73)
Inhibition of Interleukin-1β and Reduction in Atherothrombotic Cardiovascular Events in the CANTOS Trial. (2020) (72)
The “Intermediate” CD14++CD16+ monocyte subset increases in severe peripheral artery disease in humans (2016) (72)
The mechanisms by which infectious agents may contribute to atherosclerosis and its clinical manifestations. (1998) (72)
Differential blood pressure effects of ibuprofen, naproxen, and celecoxib in patients with arthritis: the PRECISION-ABPM (Prospective Randomized Evaluation of Celecoxib Integrated Safety Versus Ibuprofen or Naproxen Ambulatory Blood Pressure Measurement) Trial (2017) (72)
A Novel Prostaglandin E Receptor 4–Associated Protein Participates in Antiinflammatory Signaling (2006) (71)
CD40L induces inflammation and adipogenesis in adipose cells – a potential link between metabolic and cardiovascular disease (2010) (71)
Atherosclerosis: the path from genomics to therapeutics. (2007) (70)
Targeted Near-Infrared Fluorescence Imaging of Atherosclerosis: Clinical and Intracoronary Evaluation of Indocyanine Green. (2016) (70)
IgE actions on CD4+ T cells, mast cells, and macrophages participate in the pathogenesis of experimental abdominal aortic aneurysms (2014) (70)
Cytokines Induce Indoleamine 2,3-Dioxygenase Expression in Human Atheroma-Associated Cells: Implications for Persistent Chlamydophila pneumoniae Infection (2002) (70)
From Lipids to Inflammation : New Approaches to Reducing Atherosclerotic Risk (2016) (70)
Cytokines Regulate Genes Involved in Atherogenesis a (1994) (70)
Induction of DNA synthesis by a single transient mechanical stimulus of human vascular smooth muscle cells. Role of fibroblast growth factor-2. (1996) (70)
Fat fuels the flame: triglyceride-rich lipoproteins and arterial inflammation. (2007) (69)
Triglycerides on the rise: should we swap seats on the seesaw? (2015) (69)
Anti-inflammation Therapy by Activation of Prostaglandin EP4 Receptor in Cardiovascular and Other Inflammatory Diseases (2012) (68)
Interaction of the allogeneic state and hypercholesterolemia in arterial lesion formation in experimental cardiac allografts. (1994) (68)
Differential Effects of Human lnterleukin‐1 on Growth of Human Fibroblasts and Vascular Smooth Muscle Cells (1985) (68)
Expression of B7 molecules in recipient, not donor, mice determines the survival of cardiac allografts. (1999) (68)
Factors underlying regression of coronary atheroma with potent statin therapy. (2013) (67)
Cytokines as modulators of cell proliferation in fibrotic diseases. (1989) (67)
Smooth muscle cells of the coronary arterial tunica media express tumor necrosis factor-alpha and proliferate during acute rejection of rabbit cardiac allografts. (1995) (67)
CHIP (Clonal Hematopoiesis of Indeterminate Potential). (2018) (66)
The effect of hypoglycemia on myocardial ischemic injury during acute experimental coronary artery occlusion. (1975) (66)
Inflammation, Statin Therapy, and Risk of Stroke After an Acute Coronary Syndrome in the MIRACL Study (2007) (66)
Atherogenesis in Mice Does Not Require CD40 Ligand From Bone Marrow–Derived Cells (2005) (65)
Restenosis revisited--new targets, new therapies. (1997) (65)
Tumor Necrosis Factor Receptor–Associated Factor 1 (TRAF1) Deficiency Attenuates Atherosclerosis in Mice by Impairing Monocyte Recruitment to the Vessel Wall (2010) (65)
Macrophage migration inhibitory factor is associated with aneurysmal expansion. (2003) (65)
A ligand-specific blockade of the integrin Mac-1 selectively targets pathologic inflammation while maintaining protective host-defense (2018) (65)
Matrix matters. (2000) (65)
The Vascular Biology of Atherosclerosis (2006) (65)
Cell dysfunction in atherosclerosis and the ischemic manifestations of coronary artery disease. (1997) (64)
Peroxisome Proliferator-Activated Receptors (PPARs) and Their Role in the Vessel Wall: Possible Mediators of Cardiovascular Risk? (2001) (63)
Mast cells as mediators and modulators of atherogenesis. (2007) (63)
Fish oil and post-operative atrial fibrillation: a meta-analysis of randomized controlled trials. (2013) (63)
Influence of pre-analytical and analytical factors on soluble CD40L measurements. (2006) (63)
Effects of statins in reducing thrombotic risk and modulating plaque vulnerability (2003) (62)
Pattern of graft- and host-specific MHC class II expression in long-term murine cardiac allografts: origin of inflammatory and vascular wall cells. (1998) (62)
Monocyte Subset Dynamics in Human Atherosclerosis Can Be Profiled with Magnetic Nano-Sensors (2009) (62)
Rationale and design of the CLEAR-outcomes trial: Evaluating the effect of Bempedoic acid on cardiovascular events in patients with statin intolerance. (2020) (61)
Inflammation in diabetes mellitus: role of peroxisome proliferator-activated receptor-alpha and peroxisome proliferator-activated receptor-gamma agonists. (2007) (61)
The effect of glucose-insulin-potassium on cardiac ultrastructure following acute experimental coronary occlusion. (1973) (60)
Endothelial cell seeding of small-caliber synthetic grafts in the baboon. (1986) (59)
Endothelial and smooth muscle cells express leukocyte adhesion molecules heterogeneously during acute rejection of rabbit cardiac allografts. (1994) (59)
Cystatin C deficiency promotes inflammation in angiotensin II-induced abdominal aortic aneurisms in atherosclerotic mice. (2010) (59)
Association of Thrombospondin-1 and Cardiac Allograft Vasculopathy in Human Cardiac Allografts (2001) (59)
Plaque instability--the real challenge for atherosclerosis research in the next decade? (1999) (59)
Biological mechanisms for the clinical success of lipid-lowering in coronary artery disease and the use of surrogate end-points (1996) (58)
Molecular imaging of macrophage protease activity in cardiovascular inflammation in vivo (2011) (58)
Coinhibitory Suppression of T Cell Activation by CD40 Protects Against Obesity and Adipose Tissue Inflammation in Mice (2014) (58)
The smooth muscle cell: sinner or saint in restenosis and the acute coronary syndromes? (1998) (57)
Components of the protein fraction of oxidized low density lipoprotein stimulate interleukin-1 alpha production by rabbit arterial macrophage-derived foam cells. (1995) (57)
Inflammation during the life cycle of the atherosclerotic plaque. (2021) (56)
Angiotensin II-induced TLR4 mediated abdominal aortic aneurysm in apolipoprotein E knockout mice is dependent on STAT3. (2015) (56)
CADASIL mutations impair Notch3 glycosylation by Fringe. (2005) (56)
Long noncoding RNA SNHG12 integrates a DNA-PK–mediated DNA damage response and vascular senescence (2020) (56)
Genetically engineered resistance for MMP collagenases promotes abdominal aortic aneurysm formation in mice infused with angiotensin II (2009) (56)
Vitamin C, collagen, and cracks in the plaque. (2002) (56)
High-Intensity Statin Therapy Alters the Natural History of Diabetic Coronary Atherosclerosis: Insights From SATURN (2014) (56)
Oxidative Stress Biomarkers and Incidence of Postoperative Atrial Fibrillation in the Omega-3 Fatty Acids for Prevention of Postoperative Atrial Fibrillation (OPERA) Trial (2015) (55)
Deletion of EP4 on Bone Marrow–Derived Cells Enhances Inflammation and Angiotensin II–Induced Abdominal Aortic Aneurysm Formation (2011) (55)
Medical Therapy for Long-Term Prevention of Atherothrombosis Following an Acute Coronary Syndrome: JACC State-of-the-Art Review. (2018) (55)
Selective cathepsin S inhibition attenuates atherosclerosis in apolipoprotein E-deficient mice with chronic renal disease. (2015) (54)
"In vivo" imaging of atherosclerosis. (2012) (54)
and Attilio Maseri Inflammation and Atherosclerosis (2002) (54)
AGE-BSA decreases ABCG1 expression and reduces macrophage cholesterol efflux to HDL. (2007) (54)
Elevated release of sCD40L from platelets of diabetic patients by thrombin, glucose and advanced glycation end products (2005) (54)
The multiple facets of the fat tissue. (2008) (54)
T-cell activation leads to reduced collagen maturation in atherosclerotic plaques of Apoe(-/-) mice. (2009) (53)
Comparative analysis of cytokine induction in human vascular endothelial and smooth muscle cells. (1989) (52)
Interleukin-1β Mediates Arterial Thrombus Formation via NET-Associated Tissue Factor (2019) (52)
Influence of Helicobacter pylori Infection During Atherogenesis In Vivo in Mice (2002) (52)
Lipid Lowering Reduces Proteolytic and Prothrombotic Potential in Rabbit Atheroma a (2000) (52)
Sex-related differences of coronary atherosclerosis regression following maximally intensive statin therapy: insights from SATURN. (2013) (51)
Multiple Mechanisms of Thrombosis Complicating Atherosclerotic Plaques (2000) (51)
Immunometabolism and atherosclerosis: perspectives and clinical significance- A position paper from the working group on atherosclerosis and vascular biology of the European Society of Cardiology. (2019) (51)
Report of the National Heart, Lung, and Blood Institute working group on the translation of cardiovascular molecular imaging. (2011) (51)
Nonculprit Plaque Characteristics in Patients With Acute Coronary Syndrome Caused by Plaque Erosion vs Plaque Rupture: A 3-Vessel Optical Coherence Tomography Study (2018) (50)
Coronary Plaque Microstructure and Composition Modify Optical Polarization (2017) (50)
Glycated LDL increases monocyte CC chemokine receptor 2 expression and monocyte chemoattractant protein-1-mediated chemotaxis. (2008) (50)
Echocardiography-derived left ventricular end-systolic regional wall stress and matrix remodeling after experimental myocardial infarction. (1999) (50)
Taming Immune and Inflammatory Responses to Treat Atherosclerosis. (2018) (50)
Antiatherosclerotic Effects of Long-Term Maximally Intensive Statin Therapy After Acute Coronary Syndrome: Insights From Study of Coronary Atheroma by Intravascular Ultrasound Effect of Rosuvastatin Versus Atorvastatin (2014) (49)
Murine "model" monotheism: an iconoclast at the altar of mouse. (2015) (49)
Relationship of Interleukin-1 Blockade With Incident Gout and Serum Uric Acid Levels (2018) (49)
Premature Menopause, Clonal Hematopoiesis, and Coronary Artery Disease in Postmenopausal Women (2020) (49)
Long-term culture of contractile mammalian heart cells in a defined serum-free medium that limits non-muscle cell proliferation. (1984) (49)
Matrix Metalloproteinase-13 Predominates Over Matrix Metalloproteinase-8 as the Functional Interstitial Collagenase in Mouse Atheromata (2014) (49)
Interleukin 18 function requires both interleukin 18 receptor and Na-Cl co-transporter (2015) (48)
Cathepsin S-mediated fibroblast trans-differentiation contributes to left ventricular remodelling after myocardial infarction. (2013) (48)
Cardiac transplant graft arteriosclerosis. (1991) (48)
How does lipid lowering prevent coronary events? New insights from human imaging trials. (2015) (48)
TET2-Driven Clonal Hematopoiesis and Response to Canakinumab: An Exploratory Analysis of the CANTOS Randomized Clinical Trial. (2022) (47)
Eosinophils improve cardiac function after myocardial infarction (2019) (47)
Reduction of Infarct Size Following Coronary Occlusion (1974) (47)
Enhanced expression of CD44 variants in human atheroma and abdominal aortic aneurysm: possible role for a feedback loop in endothelial cells. (2004) (47)
Differential immunological signature at the culprit site distinguishes acute coronary syndrome with intact from acute coronary syndrome with ruptured fibrous cap: results from the prospective translational OPTICO-ACS study. (2020) (46)
Effect of pharmacologic agents on the function of the ischemic heart. (1973) (46)
Observations on human smooth muscle cell cultures from hyperplastic lesions of prosthetic bypass grafts: production of a platelet-derived growth factor-like mitogen and expression of a gene for a platelet-derived growth factor receptor--a preliminary study. (1989) (46)
Pleiotropic Anti-atherosclerotic Effects of PCSK9 Inhibitors From Molecular Biology to Clinical Translation (2018) (45)
Adiponectin Inhibits Allograft Rejection in Murine Cardiac Transplantation (2009) (45)
Association between Obstructive Sleep Apnea and Cardiovascular Risk Factors: Variation by Age, Sex, and Race. The Multi‐Ethnic Study of Atherosclerosis (2018) (45)
Tumor Necrosis Factor Receptor ‐1 and ‐2 Double Deficiency Reduces Graft Arterial Disease in Murine Cardiac Allografts (2003) (45)
Impact of statins on progression of atherosclerosis: rationale and design of SATURN (Study of Coronary Atheroma by InTravascular Ultrasound: Effect of Rosuvastatin versus AtorvastatiN) (2011) (44)
Statins Improve the Resolution of Established Murine Venous Thrombosis: Reductions in Thrombus Burden and Vein Wall Scarring (2015) (44)
Anticytokine Immune Therapy and Atherothrombotic Cardiovascular Risk. (2019) (44)
Point-of-Care Technologies for Precision Cardiovascular Care and Clinical Research (2016) (44)
Interferon-gamma-secreting T-cell populations in rejecting murine cardiac allografts: assessment by flow cytometry. (1998) (43)
Interferon-γ Released by Activated CD8+ T Lymphocytes Impairs the Calcium Resorption Potential of Osteoclasts in Calcified Human Aortic Valves. (2017) (43)
Plasma concentration of heat shock protein 27 and risk of cardiovascular disease: a prospective, nested case-control study. (2008) (43)
Lipoprotein Disorders and Cardiovascular Disease (2012) (43)
Cytokines as mediators of vascular pathology. (1992) (43)
Association of B7-1 co-stimulation with the development of graft arterial disease. Studies using mice lacking B7-1, B7-2, or B7-1/B7-2. (2000) (43)
Improved characterization of atherosclerotic plaques by gadolinium contrast during intravascular magnetic resonance imaging of human arteries. (2008) (42)
Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine, Single Volume, 9th Edition (2010) (42)
Acute rejection accelerates graft coronary disease in transplanted rabbit hearts. (1995) (42)
Lesion versus lumen (1995) (42)
Lipid lowering improves endothelial functions. (2000) (42)
Diversity of T-cell antigen receptor V beta gene utilization in advanced human atheroma. (1994) (42)
Inflammation and thrombosis – testing the hypothesis with anti- inflammatory drug trials (2016) (41)
Regulatory T cells in human and angiotensin II-induced mouse abdominal aortic aneurysms. (2015) (41)
Annexin A1–dependent tethering promotes extracellular vesicle aggregation revealed with single–extracellular vesicle analysis (2020) (41)
Atheroma Susceptible to Thrombosis Exhibit Impaired Endothelial Permeability In Vivo as Assessed by Nanoparticle-Based Fluorescence Molecular Imaging (2017) (40)
Targeting Inflammatory Pathways in Cardiovascular Disease: The Inflammasome, Interleukin-1, Interleukin-6 and Beyond (2021) (40)
Activated endothelial cells resist lymphokine-activated killer cell-mediated injury. Possible role of induced cytokines in limiting capillary leak during IL-2 therapy. (1989) (40)
Effects of chymostatin and other proteinase inhibitors on protein breakdown and proteolytic activities in muscle. (1980) (40)
Superficial erosion and the precision management of acute coronary syndromes: not one-size-fits-all (2017) (39)
Pathogenic mechanisms of atherosclerosis: effect of lipid lowering on the biology of atherosclerosis. (1996) (39)
Effect of a Cleavage-Resistant Collagen Mutation on Left Ventricular Remodeling (2003) (39)
Allograft arteriosclerosis and immune-driven angiogenesis. (2003) (38)
All roads lead to IL-6: A central hub of cardiometabolic signaling. (2018) (38)
Immunopathology of coronary arteriosclerosis in transplanted hearts. (1992) (37)
Lack of EP4 receptors on bone marrow-derived cells enhances inflammation in atherosclerotic lesions. (2011) (37)
Vasospasm of Atherosclerotic Coronary Arteries Precipitates Acute Ischemic Myocardial Damage in Myocardial Infarction–Prone Strain of the Watanabe Heritable Hyperlipidemic Rabbits (2013) (37)
Regulation of the Thrombotic Potential of Atheroma (1999) (37)
Ligation of CD40 on Vascular Smooth Muscle Cells Mediates Loss of Interstitial Collagen via Matrix Metalloproteinase Activity (2001) (37)
Mechanisms of acute coronary syndromes. (2013) (37)
Randomised clinical trial: gastrointestinal events in arthritis patients treated with celecoxib, ibuprofen or naproxen in the PRECISION trial (2018) (35)
Local cytokine environments drive aneurysm formation in allografted aortas. (2005) (35)
Molecular mediators of arterial inflammation: a role for microbial products? (1999) (35)
Loss of Myeloid Related Protein-8/14 Exacerbates Cardiac Allograft Rejection (2011) (35)
Atheromas that cause fatal thrombosis are usually large and frequently accompanied by vessel enlargement. (2001) (35)
Liberation of desmosine and isodesmosine as amino acids from insoluble elastin by elastolytic proteases. (2011) (35)
Interferon-beta. A potential autocrine regulator of human vascular smooth muscle cell growth. (1992) (34)
Endothelial dysfunctions and vascular disease (2007) (34)
Optical coherence tomography in coronary atherosclerosis assessment and intervention (2022) (34)
Cathepsin G activity lowers plasma LDL and reduces atherosclerosis. (2014) (34)
Cold ischemia induces isograft arteriopathy, but does not augment allograft arteriopathy in non-immunosuppressed hosts. (2002) (34)
Adipocytes promote interleukin-18 binding to its receptors during abdominal aortic aneurysm formation in mice. (2019) (34)
Inflammation, Aging, and Cardiovascular Disease: JACC Review Topic of the Week. (2022) (34)
CXCR3 Controls T-Cell Accumulation in Fat Inflammation (2010) (34)
Lipoprotein(a) and coronary atheroma progression rates during long-term high-intensity statin therapy: Insights from SATURN. (2017) (33)
A Rock and a Hard Place: Chiseling Away at the Multiple Mechanisms of Aortic Stenosis (2017) (33)
Acute mental stress drives vascular inflammation and promotes plaque destabilization in mouse atherosclerosis (2021) (33)
Effects of Interleukin-1 β Inhibition on Blood Pressure, Incident Hypertension, and Residual Inﬂammatory Risk A Secondary Analysis of CANTOS (2019) (33)
Mechanisms of Myeloid Cell Modulation of Atherosclerosis. (2016) (33)
Differences in Safety of Nonsteroidal Antiinflammatory Drugs in Patients With Osteoarthritis and Patients With Rheumatoid Arthritis (2018) (32)
Effects of Interleukin-1β Inhibition on Blood Pressure, Incident Hypertension, and Residual Inflammatory Risk (2019) (32)
Nanoparticle PET-CT Detects Rejection and Immunomodulation in Cardiac Allografts (2013) (32)
Effect of Aspirin Coadministration on the Safety of Celecoxib, Naproxen, or Ibuprofen. (2018) (32)
The ω-3 Fatty Acids for Prevention of Post-Operative Atrial Fibrillation trial--rationale and design. (2011) (32)
LncRNA VINAS regulates atherosclerosis by modulating NF-κB and MAPK signaling (2020) (32)
Cryopreserved aortic homografts contain viable smooth muscle cells capable of expressing transplantation antigens. (1993) (32)
Tension in the plaque: hypoxia modulates metabolism in atheroma. (2011) (31)
Investigating Lipid-Modulating Agents for Prevention or Treatment of COVID-19 (2021) (31)
in Human Vascular Smooth Muscle Cells (1986) (31)
Comprar Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine, Single Volume, 9th Edition | Robert O. Bonow | 9781437703986 | Saunders (2010) (30)
Atherosclerotic plaque inflammation: the final frontier? (2004) (30)
Activation of prostaglandin E2-EP4 signaling reduces chemokine production in adipose tissue[S] (2015) (29)
Evolution and stabilization of vulnerable atherosclerotic plaques. (2001) (29)
Endotoxinemia Accelerates Atherosclerosis via Electrostatic Charge-Mediated Monocyte Adhesion. (2020) (29)
S100A9-RAGE Axis Accelerates Formation of Macrophage-Mediated Extracellular Vesicle Microcalcification in Diabetes Mellitus (2020) (29)
The JAK-STAT pathway: an emerging target for cardiovascular disease in rheumatoid arthritis and myeloproliferative neoplasms. (2021) (29)
Acute rejection: culprit or coincidence in the pathogenesis of cardiac graft vascular disease? (1995) (29)
Leukocyte Integrin Mac-1 Promotes Acute Cardiac Allograft Rejection (2008) (28)
Triglyceride-Rich Lipoproteins and Atherosclerotic Cardiovascular Disease (2016) (28)
Clonal Hematopoiesis Confers Predisposition to Both Cardiovascular Disease and Cancer: A Newly Recognized Link Between Two Major Killers (2018) (28)
The role of Protein breakdown in growth, quiescence, and starvation of vascular smooth muscle cells (1984) (28)
Atheroprotection through SYK inhibition fails in established disease when local macrophage proliferation dominates lesion progression (2016) (28)
Allergic Lung Inflammation Aggravates Angiotensin II–Induced Abdominal Aortic Aneurysms in Mice (2016) (28)
Drilling for oxygen: angiogenesis involves proteolysis of the extracellular matrix. (2001) (28)
Role for Anti-Cytokine Therapies in Severe Coronavirus Disease 2019 (2020) (28)
Lipid lowering therapy in atherosclerosis. (2004) (28)
Analysis of the mitogenic effect of fetuin preparations on arterial smooth muscle cells: The role of contaminant platelet‐derived growth factor (1985) (28)
Association of Diet Quality With Prevalence of Clonal Hematopoiesis and Adverse Cardiovascular Events. (2021) (28)
Early proliferation of medial smooth muscle cells in coronary arteries of rabbit cardiac allografts during immunosuppression with cyclosporine A. (1995) (27)
Gene therapy of restenosis: promise and perils. (1998) (27)
Bone Marrow Endothelial Cells Regulate Myelopoiesis in Diabetes Mellitus (2020) (26)
New Insights into Plaque Stabilisation by Lipid Lowering (2012) (26)
Comparison of the control and pathways for degradation of the acetylcholine receptor and average protein in cultured muscle cells (1981) (25)
Self-reactive CD4+ IL-3+ T cells amplify autoimmune inflammation in myocarditis by inciting monocyte chemotaxis (2019) (25)
The inhibition of endothelial activation by unsaturated fatty acids (2007) (24)
Adiponectin inhibits macrophage tissue factor, a key trigger of thrombosis in disrupted atherosclerotic plaques. (2013) (24)
Elevations in neutrophils with obstructive sleep apnea: The Multi-Ethnic Study of Atherosclerosis (MESA). (2018) (24)
Endothelial Functions and Dysfunctions (2007) (24)
The active roles of cells of the blood vessel wall in health and disease. (1987) (23)
Effects of Interleukin-1 (cid:1) Inhibition With Canakinumab on Hemoglobin A1c, Lipids, C-Reactive Protein, Interleukin-6, and Fibrinogen A Phase IIb Randomized, Placebo-Controlled Trial (2012) (23)
B lymphocyte-derived acetylcholine limits steady-state and emergency hematopoiesis (2022) (23)
Imaging Granzyme B Activity Assesses Immune-Mediated Myocarditis. (2015) (23)
Fanning the flames: inflammation in cardiovascular diseases. (2015) (23)
Stabilization of atherosclerotic plaques: New mechanisms and clinical targets (2003) (23)
Reduction of protein degradation and atrophy in cultured fetal mouse hearts by leupeptin. (1979) (23)
PPARa Activators Inhibit Cytokine-Induced Vascular Cell Adhesion Molecule-1 Expression in Human Endothelial Cells (1999) (22)
Histological evidence of concomitant intramyocardial and epicardial vasculitis in necropsied heart allografts: a possible relationship with graft coronary arteriosclerosis. (1999) (22)
The ins and outs of inflammatory cells in atheromata. (2012) (22)
Do vascular wall cytokines promote atherogenesis? (1992) (21)
EP4 Receptor–Associated Protein in Macrophages Ameliorates Colitis and Colitis-Associated Tumorigenesis (2015) (21)
Induction of Endothelial-Leukocyte Interaction by Interferon-γ Requires Coactivation of Nuclear Factor-κB (2001) (21)
Neutrophil extracellular traps: from physiology to pathology. (2021) (21)
Braunwald's heart disease [ressource électronique] : a textbook of cardiovascular medicine (2008) (21)
THE DIRECT EFFECT OF INJECTABLE CYCLOSPORINE AND ITS VEHICLE, CREMOPHOR, ON ENDOTHELIAL VASCULAR CELL ADHESION MOLECULE‐1 EXPRESSION1 RICINOLEIC ACID INHIBITS CORONARY ARTERY ENDOTHELIAL ACTIVATION (1995) (21)
The Clinical Challenge of Clonal Hematopoiesis, a Newly Recognized Cardiovascular Risk Factor. (2020) (21)
Safety and efficacy of achieving very low low-density lipoprotein cholesterol levels with rosuvastatin 40 mg daily (from the ASTEROID Study). (2009) (21)
Eosinophils Protect Mice From Angiotensin-II Perfusion–Induced Abdominal Aortic Aneurysm (2020) (21)
Differential Roles of Cysteinyl Cathepsins in TGF-β Signaling and Tissue Fibrosis (2019) (21)
Inflammation and cardiovascular disease mechanisms 1 – 3 (2006) (20)
Metformin and vascular protection: a cardiologist's view. (2003) (20)
Molecular imaging of atherosclerosis: a progress report. (2010) (20)
Increased intermediate CD14++CD16++ monocyte subset levels associate with restenosis after peripheral percutaneous transluminal angioplasty. (2016) (20)
IgE stimulates human and mouse arterial cell apoptosis and cytokine expression and promotes atherogenesis in Apoe-/- mice. (2018) (19)
Interleukin-1β suppression dampens inflammatory leucocyte production and uptake in atherosclerosis (2021) (19)
Primary and Secondary Prevention of Coronary Heart Disease (2012) (19)
The dawn of a new era of targeted lipid-lowering therapies. (2022) (19)
Targeted delivery of Protein Arginine Deiminase-4 inhibitors to limit arterial intimal NETosis and preserve endothelial integrity. (2021) (19)
North American Thrombosis Forum, AF Action Initiative Consensus Document. (2016) (19)
Cathepsin G deficiency reduces periaortic calcium chloride injury-induced abdominal aortic aneurysms in mice. (2015) (18)
Combined non-invasive assessment of endothelial shear stress and molecular imaging of inflammation for the prediction of inflamed plaque in hyperlipidaemic rabbit aortas (2017) (18)
Asthma Associates With Human Abdominal Aortic Aneurysm and Rupture (2016) (18)
Fish Oil and Perioperative Bleeding: Insights From the OPERA Randomized Trial (2018) (18)
Cathepsin K Deficiency Ameliorates Systemic Lupus Erythematosus-like Manifestations in Faslpr Mice (2017) (18)
Comprar Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine, 2-Volume Set, 10th Edition | Douglas P. Zipes | 9781455751334 | Saunders (2014) (17)
Mendelian randomization supports bidirectional causality between telomere length and clonal hematopoiesis of indeterminate potential (2022) (17)
Risk Markers for Atherothrombotic Disease (2012) (17)
Postischemic Administration of IL-1α Neutralizing Antibody Reduces Brain Damage and Neurological Deficit in Experimental Stroke. (2020) (17)
Task Force #3—What Is the Spectrum of Current and Emerging Techniques for the Noninvasive Measurement of Atherosclerosis? (2003) (17)
Redundancy of IL-1 Isoform Signaling and Its Implications for Arterial Remodeling (2016) (17)
Na+-H+ exchanger 1 determines atherosclerotic lesion acidification and promotes atherogenesis (2019) (17)
Biomarkers: A Challenging Conundrum in Cardiovascular Disease (2015) (17)
Matrix metalloproteinases: not-so-innocent bystanders in heart failure. (2000) (17)
CC Chemokine Receptor-1 Activates Intimal Smooth Muscle-Like Cells in Graft Arterial Disease (2009) (17)
Assisted Living in the Atheroma: Elderly Macrophages Promote Plaques. (2016) (16)
Retinoids Repress Human Cardiovascular Cell Calcification With Evidence for Distinct Selective Retinoid Modulator Effects (2019) (16)
New Insights Into Plaque Erosion as a Mechanism of Acute Coronary Syndromes. (2021) (16)
2417Elevated interleukin-6 and interleukin-18 concentrations predict residual inflammatory risk both before and after interleukin-1beta inhibition with canakinumab (2019) (16)
Loss-of-Function Mutations in Dnmt3a and Tet2 Lead to Accelerated Atherosclerosis and Convergent Macrophage Phenotypes in Mice (2018) (16)
Endogenous tissue plasminogen activator and risk of recurrent cardiac events after an acute coronary syndrome in the MIRACL study. (2009) (16)
Mesenchymal target cell specificity of egg granuloma-derived fibroblast growth factor in schistosomiasis. (1987) (16)
Dysregulation of IL-33/ST2 signaling and myocardial periarteriolar fibrosis. (2019) (15)
Paclitaxel Drug-Coated Balloon Angioplasty Suppresses Progression and Inflammation of Experimental Atherosclerosis in Rabbits (2020) (15)
Collaborative multidisciplinary workshop report: interface of lipid metabolism, atherosclerosis, and Chlamydia infection. (2000) (15)
Bone marrow endothelial dysfunction promotes myeloid cell expansion in cardiovascular disease (2021) (15)
Cathepsin K-deficiency impairs mouse cardiac function after myocardial infarction. (2019) (15)
Ligation of CD 40 Activates Interleukin 1 b-converting Enzyme ( Caspase-1 ) Activity in Vascular Smooth Muscle and Endothelial Cells and Promotes Elaboration of Active Interleukin 1 b * (1997) (15)
Plasma Pentraxin 3 Levels Do Not Predict Coronary Events but Reflect Metabolic Disorders in Patients with Coronary Artery Disease in the CARE Trial (2014) (15)
Elaboration by mammalian mesenchymal cells infected with Trypanosoma cruzi of a fibroblast-stimulating factor that may contribute to chagasic cardiomyopathy (1987) (14)
Once more unto the breach: endothelial permeability and atherogenesis. (2019) (14)
Nanoparticles targeting extra domain B of fibronectin-specific to the atherosclerotic lesion types III, IV, and V-enhance plaque detection and cargo delivery (2018) (14)
Introducing JACC: Basic to Translational Science (2016) (14)
CD74 Deficiency Mitigates Systemic Lupus Erythematosus–like Autoimmunity and Pathological Findings in Mice (2017) (14)
Vascular cells have limited capacities to activate and differentiate T cells: implications for transplant vascular sclerosis. (1997) (14)
EPA and DHA containing phospholipids have contrasting effects on membrane structure (2021) (14)
of the National Heart , Lung , and Blood Institute – National Institute of Diabetes and Digestive and Kidney Diseases Working Group on Cardiovascular Complications of Type 1 Diabetes Mellitus (2005) (14)
Inhibiting NLRP3 Inflammasome Activity in Acute Myocardial Infarction: A Review of Pharmacologic Agents and Clinical Outcomes. (2019) (13)
Allergic lung inflammation promotes atherosclerosis in apolipoprotein E-deficient mice. (2016) (13)
Effect of atorvastatin on C-reactive protein in patients with acute coronary syndromes: a substudy of the MIRACL trial (2002) (13)
A guanidine-rich regulatory oligodeoxynucleotide improves type-2 diabetes in obese mice by blocking T-cell differentiation (2012) (13)
Bone marrow: a fountain of vascular youth? (2003) (13)
In Vivo Nanoparticle Assessment of Pathological Endothelium Predicts the Development of Inflow Stenosis in Murine Arteriovenous Fistula (2015) (13)
Over a hump for imaging atherosclerosis: nanobodies visualize vascular cell adhesion molecule-1 in inflamed plaque. (2012) (13)
C-reactive protein and coronary heart disease. (2004) (13)
Wild-type but not interferon-gamma-deficient T cells induce graft arterial disease in the absence of B cells. (2004) (12)
Increased prevalence of clonal hematopoiesis of indeterminate potential amongst people living with HIV (2022) (12)
current as Activation of Mononuclear Cells CD 14 Is an Essential Receptor for HSP 60 Activates the Innate Immune Response : Cutting Edge : Heat Shock Protein ( HSP ) 60 (1999) (12)
Activation of Smooth Muscle and Endothelial Cells following Balloon Injury a (1994) (12)
Optical Coherence Tomography of Plaque Erosion: JACC Focus Seminar Part 2/3. (2021) (12)
Relationship of antihypertensive treatment to plasma markers of vascular inflammation and remodeling in the Comparison of Amlodipine versus Enalapril to Limit Occurrences of Thrombosis study. (2012) (12)
Cardiovascular Benefits of GLP-1 Receptor Agonism (2018) (11)
Effects of Interleukin-1β Inhibition on Incident Anemia (2020) (11)
Silencing of CCR 2 in myocarditis (2015) (11)
Time-Restricted Salutary Effects of Blood Flow Restoration on Venous Thrombosis and Vein Wall Injury in Mouse and Human Subjects. (2021) (11)
Salvage of myocardial tissue by coronary artery reperfusion following acute coronary occlusion (1972) (11)
Increased CHIP Prevalence Amongst People Living with HIV (2020) (11)
Induction of endothelial-leukocyte interaction by interferon-gamma requires coactivation of nuclear factor-kappaB. (2001) (11)
Systemic Thrombin Inhibition by Hirulog Does Not Alter Medial Smooth Muscle Cell Proliferation and Inflammatory Activation after Vascular Injury in the Rabbit (1999) (10)
Interferon-γ-Secreting T-Cell Populations in Rejecting Murine Cardiac Allografts (1998) (10)
Lp-PLA2 Antagonizes Left Ventricular Healing After Myocardial Infarction by Impairing the Appearance of Reparative Macrophages (2015) (10)
The role of eicosapentaenoic acid in reducing important cardiovascular events, including coronary revascularization. (2021) (10)
Systems Approach to Discovery of Therapeutic Targets for Vein Graft Disease (2021) (10)
The biology of atherosclerosis comes full circle: lessons for conquering cardiovascular disease (2021) (10)
The Dynamic Nature of Vascular Endothelial Functions (1987) (10)
Dietary cholesterol is essential to mast cell activation and associated obesity and diabetes in mice. (2019) (10)
COVID Coronary Vascular Thrombosis: Correlation with Neutrophil but not Endothelial Activation (2021) (10)
Cardiovascular Disease in Myeloproliferative Neoplasms (2022) (10)
Jak-ing Up the Plaque's Lipid Core…and Even More. (2018) (9)
Linking regulation of nitric oxide to endothelin-1: The Yin and Yang of vascular tone in the atherosclerotic plaque. (2019) (9)
Rabbit Models of Atherosclerosis (2001) (9)
Arterial Inflammation: The Heat Before the Storm. (2019) (9)
Inflammation goes with the flow: implications for non-invasive identification of high-risk plaque. (2014) (9)
Resilience of the Internal Mammary Artery to Atherogenesis: Shifting From Risk to Resistance to Address Unmet Needs (2021) (9)
The cardiovascular-dialysis nexus: the transition to dialysis is a treacherous time for the heart. (2021) (9)
CHIPping Away at the Pathogenesis of Heart Failure. (2019) (9)
The March of Monocytes in Atherosclerosis: One Cell at a Time. (2020) (9)
Vascular inflammation and activation: new targets for lipid lowering (2001) (9)
Inflammation and Cardiac Diseases (2003) (9)
Internal Bleeding (2018) (8)
Seeing and Sampling the Surface of the Atherosclerotic Plaque: Red or White Can Make Blue. (2016) (8)
How Our Growing Understanding of Inflammation Has Reshaped the Way We Think of Disease and Drug Development (2010) (8)
Matrix Metalloproteinases in Cardiovascular Diseases (2017) (8)
Deletion of the phosphoinositide 3-kinase p 110 { gamma } gene attenuates murine (2007) (8)
ATHEROSCLEROSIS: THE NEW VIEW.: THE NEW VIEW. (2002) (8)
Fluorodeoxyglucose Uptake in Atheroma: Not So Simple. (2019) (8)
IgE actions on CD 4 + T cells , mast cells , and macrophages participate in the pathogenesis of experimental abdominal aortic aneurysms (2014) (8)
Counterregulation rules in atherothrombosis. (2012) (8)
TNF‐α antagonism rescues the effect of ageing on stroke: Perspectives for targeting inflamm‐ageing (2021) (8)
Targeting RNA to lower triglycerides: long strides from short molecules (2019) (8)
TP53-mediated clonal hematopoiesis confers increased risk for incident peripheral artery disease (2021) (8)
Role of Omega-3 Fatty Acids in Cardiovascular Disease: the Debate Continues (2022) (8)
Immune And Inflammatory Mechanisms Mediate Cardiovascular Diseases From Head To Toe. (2021) (8)
Lipid-lowering therapy stabilizes plaque, reduces events by limiting inflammation. (2002) (8)
Colony stimulating factor-1 producing endothelial cells and mesenchymal stromal cells maintain monocytes within a perivascular bone marrow niche. (2022) (8)
Gaps in beliefs and practice in dyslipidaemia management in Japan, Germany, Colombia and the Philippines: insights from a web-based physician survey (2020) (8)
Nontraditional coronary risk factors and vascular biology: the frontiers of preventive cardiology. (1998) (7)
Inflammation drives residual risk in chronic kidney disease: a CANTOS substudy. (2022) (7)
Peripheral Artery Diseases (2012) (7)
Deficiencies of IL-4 or TNF-alpha receptor-1 do not diminish graft arteriosclerosis in cardiac allografts. (1999) (7)
Production of Cytokines by Vascular Wall Cells: An Update and Implications for Atherogenesis (1991) (7)
Indium-111 labeled platelet imaging of endothelial-cell-seeded small-caliber synthetic grafts in the baboon (1985) (7)
Low-Density Lipoprotein Cholesterol After an Acute Coronary Syndrome: How Low to Go? (2019) (7)
How Far We Have Come, How Far We Have Yet to Go in Atherosclerosis Research. (2020) (7)
Lipoprotein (a) (2016) (7)
Advances in Imaging of Cardiac Allograft Rejection (2010) (7)
3.P.390 Ligation of CD40 on macrophage induces matrix metalloproteinases and tissue factor expression (1997) (7)
Act Local, Act Global⁎⁎Editorials published in the Journal of the American College of Cardiologyreflect the views of the authors and do not necessarily represent the views of JACCor the American College of Cardiology. (2005) (6)
Adaptive immunity in acute coronary syndromes: chicken or egg? (2018) (6)
Chapter 20 Future directions and therapeutic approaches (1993) (6)
Stirring the soup of innate immunity in the acute coronary syndromes. (2010) (6)
Unfriendly Fire From Neutrophils Promiscuously Potentiates Cardiovascular Inflammation. (2017) (6)
You can't run from inflammation: lower extremity ischemia, hypoxia signaling, and macrophage subtypes. (2012) (6)
Braunwald's Heart Disease: a textbook of cardiovascular medicine volume 1 (2015) (6)
The European Heart Journal: leading the fight to reduce the global burden of cardiovascular disease. (2020) (6)
Genetically modified endothelial cells in the treatment of human diseases. (1989) (6)
Abstract 11539: Innate Response Activator B Cells Aggravate Atherosclerosis by Stimulating Th1 Adaptive Immunity (2013) (6)
Swell, or Not Too Swell: Cytokines Regulate Arterial Aneurysm Formation. (2017) (6)
Inflammation — A new frontier in cardiac disease and therapeutics (2003) (6)
Sleep modulates haematopoiesis and protects against atherosclerosis (2019) (6)
Antibody-based immunotherapy targeting cytokines and atherothrombotic cardiovascular diseases: A review for future perspectives. (2020) (6)
A tale of two therapies lipid-lowering vs anti-inflammatory therapy - a false dichotomy? (2020) (6)
Prothymosin Alpha: A Novel Contributor to Estradiol Receptor Alpha-Mediated CD8+ T-Cell Pathogenic Responses and Recognition of Type 1 Collagen in Rheumatic Heart Valve Disease. (2022) (5)
A biological rationale for the disparate effects of omega-3 fatty acids on cardiovascular disease outcomes. (2022) (5)
Lancet Seminar: Cardiovascular Remodelling in Coronary Artery Disease and Heart Failure + (2015) (5)
Reduced Nhe1 (Na+-H+ Exchanger-1) Function Protects ApoE-Deficient Mice From Ang II (Angiotensin II)–Induced Abdominal Aortic Aneurysms (2020) (5)
Deficiency of mouse mast cell protease 4 mitigates cardiac dysfunctions in mice after myocardium infarction. (2018) (5)
Abstract 16180: K-877, A Novel PPAR-alpha Selective Agonist, Suppresses Macrophage Activation and Arterial Lesion Formation (2013) (5)
Metalloproteinases and Atherosclerotic Plaque Rupture (1997) (5)
Chasing LDL cholesterol to the bottom — PCSK9 in perspective (2022) (5)
The Aging Cardiovascular System (2017) (5)
Comprar Achieving Cultural Competency: A Case-Based Approach to Training Health Professionals | Raffaele De Caterina | 9781405180726 | Wiley (2009) (5)
Peroxisome Proliferator-Activated Receptor-g Activators Inhibit IFN- g-Induced Expression of the T Cell-Active CXC Chemokines IP-10, Mig, and I-TAC in Human Endothelial Cells (2000) (5)
ALX-chemy: adding spice to the inflammatory soup of atherosclerosis. (2015) (5)
Morphological changes in cultured myotubes treated with agents that interfere with lysosomal function (2004) (5)
The potential benefits of aspirin for primary cardiovascular prevention in rheumatoid arthritis: a secondary analysis of the PRECISION Trial (2018) (5)
Arteriosclerosis, Thrombosis, and Vascular Biology. (2017) (5)
Clinical and intracoronary evaluation of indocyanine green for targeted near-infrared fluorescence imaging of atherosclerosis (2016) (5)
Near-Infrared Autofluorescence in Atherosclerosis Associates With Ceroid and Is Generated by Oxidized Lipid-Induced Oxidative Stress (2021) (5)
Lipid-Modulating Agents for Prevention or Treatment of COVID-19 in Randomized Trials (2021) (5)
COVID-19, the Pandemic of the Century and Its Impact on Cardiovascular Diseases (2021) (5)
INCREASED MICROVASCULAR BLOOD FLOW AND PERMEABILITY ASSOCIATES WITH FDG SIGNAL IN HUMAN ATHEROMA (2012) (5)
Angiotensin II-induced TLR 4 mediated abdominal aortic aneurysm in Apolipoprotein E knockout mice is dependent on STAT 3 (2015) (5)
Abstract 5537: Toll-Like 2 Receptor Mediates Apolipoprotein CIII-Induced Monocyte Activation (2008) (5)
What happens inside an atherosclerotic plaque (2004) (5)
Cytokines score a knockout. Harnessing gene targeting to gain insight into the pathogenesis of myocarditis. (1997) (4)
Towards an understanding of the molecular pathogenesis of acute coronary syndromes. (1997) (4)
Tilting at the tilted protease balance in arterial aneurysmal disease. (2017) (4)
Deficiency of FcϵR1 Increases Body Weight Gain but Improves Glucose Tolerance in Diet-Induced Obese Mice. (2015) (4)
Arteriosclerosis in transplanted hearts: too much and too soon. (1991) (4)
Comprar Braunwald's Heart Disease Online | Peter Libby | 9781416041030 | Saunders (2007) (4)
Summary: Immune and inflammatory modulators as potential therapeutic targets for cardiac diseases (2003) (4)
Regulation of protein degradation in skeletal muscle. (2003) (4)
IL18 signaling causes islet β cell development and insulin secretion via different receptors on acinar and β cells. (2022) (4)
Endothelial Activation and the Initiation of Atherosclerosis (2007) (4)
Atorvastatin Reduces In Vivo Fibrin Deposition and Macrophage Accumulation, and Improves Primary Patency Duration and Maturation of Murine Arteriovenous Fistula. (2020) (4)
Fundamental Pathobiology of Coronary Atherosclerosis and Clinical Implications for Chronic Ischemic Heart Disease Management-The Plaque Hypothesis: A Narrative Review. (2022) (4)
INTRAVASCULAR ULTRASOUND EVALUATION OF THE EFFECT OF ROSUVASTATIN VERSUS ATORVASTATIN ON PROGRESSION OF CORONARY ATHEROSCLEROSIS: DESIGN OF THE SATURN STUDY (2008) (4)
Fatty acid modulation of endothelial activation 1 – 3 (1999) (4)
Inflammation: a common pathway in cardiovascular diseases (2003) (4)
In ﬂ ammation, Immunity, and Infection in Atherothrombosis (2018) (4)
Inducible gene expression in vascular wall cells and lesional leukocytes. (1992) (4)
Allergic asthma is a risk factor for human cardiovascular diseases (2022) (4)
Abstract 2036: In Vivo Imaging of Protease Activity in Atherosclerosis Using A Near-Infrared Fluorescence Intravascular Catheter (2006) (4)
Obesity, Inflammation, and Atherosclerosis: Shared Pathways of Cardiometabolic Disease (2011) (4)
Abstract 3373: MRP-8/14 is Critical for the Biological Response to Vascular Injury (2008) (4)
Triumph of the heart: The story of statins (2010) (4)
The Myocardium: More Than Myocytes. (2019) (4)
Endothelium: A Coordinator of Acute and Chronic Inflammation (2018) (4)
Future Directions and Therapeutic Approaches (1993) (4)
CD 40 L induces inflammation and adipogenesis in adipose cells – a potential link between metabolic and cardiovascular disease (2018) (4)
Highly Selective PPARα (Peroxisome Proliferator-Activated Receptor α) Agonist Pemafibrate Inhibits Stent Inflammation and Restenosis Assessed by Multimodality Molecular-Microstructural Imaging. (2021) (4)
Perplexity of plaque proteinases. (2006) (4)
Prospective Evaluation of Clinico-pathological Predictors of Post-operative Atrial Fibrillation: An Ancillary Study from the OPERA Trial. (2020) (4)
Myeloid-related protein 8 / 14 and the risk of cardiovascular death or myocardial infarction after an acute coronary syndrome in the Pravastatin or Atorvastatin Evaluation and Infection Theraphy : Thrombolysis in Myocardial Infarction (2009) (3)
Mig, and I-TAC in Human Endothelial Cells of the T Cell-Active CXC Chemokines IP-10, -Induced Expression g Activators Inhibit IFN-g Peroxisome Proliferator-Activated Receptor-Jorge (2000) (3)
Endothelial Activation Potentiates Neointimal Lesion Formation in the Rabbit Aorta after Balloon Injury a (1997) (3)
TP53-mediated clonal hematopoiesis confers increased risk for incident atherosclerotic disease (2023) (3)
The acute coronary syndromes: have our tools constrained our thinking? (2000) (3)
Oxidized Low‐Density Lipoprotein Induces Macrophage Production of Prothrombotic Microparticles (2020) (3)
The future of living well to 100. (2006) (3)
Neutrophil-to-lymphocyte ratio predicts cardiovascular events in patients with type 2 diabetes: post hoc analysis of SUSTAIN 6 and PIONEER 6 (2021) (3)
chapter 7 – Pathophysiology of Vasculitis (2006) (3)
Short Communication Macrophages in Human Atheroma Contain PPARg Differentiation-Dependent Peroxisomal Proliferator-Activated Receptor g (PPARg) Expression and Reduction of MMP-9 Activity through PPARg Activation in Mononuclear Phagocytes in Vitro (1998) (3)
Secondary Prevention of Coronary Artery Disease : the Role of ACE Inhibitors Established by the EUROPA and PREAMI Studies(Special Lecture 3,The 70th Anniversary Annual Scientific Meeting of the Japanese Circulation Society) (2006) (3)
Casting NETs to predict cardiovascular outcomes (2018) (3)
Tu-W24:4 Metformin inhibits proinflammatory responses in human vascular wall cells: Inhibition of nuclear factor-kappa B signaling in smooth muscle cells (2006) (3)
and Migration in Human Vascular Smooth Muscle Cells Peroxisome Proliferator-Activated Receptor Gamma Activators Inhibit Gene Expression (1998) (3)
Reducing the risk of atherosclerosis: the role of high-density lipoprotein cholesterol (2004) (3)
Regulation of protein degradation in skeletal muscle (1980) (3)
Inflammatory markers are useful risk assessment tools. (2003) (3)
Targeted Near-Infrared Fluorescence Imaging of Atherosclerosis (2016) (3)
and Atherosclerotic Cardiovascular Disease (2009) (3)
Myeloid-Related Protein-8/14 and the Risk of Cardiovascular Death or Myocardial Infarction after an Acute Coronary Syndrome in the PROVE IT-TIMI 22 Trial (2009) (3)
A winter's tale: report from the First Annual Canadian Biomarkers and Surrogate Endpoints Symposium. (2009) (3)
3.P.258 CD40 ligation on smooth muscle cells induces expression of matrix metalloproteinases: Implication for plaque rupture? (1997) (3)
A HIGHLY SELECTIVE PPARα AGONIST K-877 SUPPRESSES NEOINTIMA FORMATION FOLLOWING CORONARY STENTING IN SWINE (2016) (3)
Chapter 5 Vascular lesion formation (1993) (3)
A pivotal role for Nrf2 in endothelial detachment-implications for endothelial erosion of stenotic plaques (2019) (3)
Chapter 8 – Atherosclerosis (2013) (3)
c-Myb Exacerbates Atherosclerosis through Regulation of Protective IgM-Producing Antibody-Secreting Cells. (2019) (3)
Statin drugs might boost healthy gut microbes (2020) (3)
Vascular Lesion Formation (1993) (3)
Editors' Consensus Report The American Journal of Cardiology and Journal of Periodontology Editors' Consensus: Periodontitis and Atherosclerotic Cardiovascular Disease r (2009) (3)
Genome-wide pleiotropy analysis of coronary artery disease and pneumonia identifies shared immune pathways (2021) (3)
Molecular Imaging of Coronary Atherosclerosis (2014) (3)
Mechanisms of Plaque Progression and Complications (2007) (3)
2.P.21 The HMG-CoA reductase inhibitors atorvastatin and lovastatin reduce accumulation of collagenase and 92-kD gelatinase released by cultured human monocytic and vascular smooth muscle cells (1997) (3)
chapter 20 – Inflammation and Immunity in Atherogenesis (2004) (3)
CHAPTER 5 – Lipoproteins: Mechanisms for Atherogenesis and Progression of Atherothrombotic Disease (2009) (3)
Proprotein Convertase Subtilisin/Kexin 9 (PCSK9) Promotes Macrophage Activation via LDL Receptor-Independent Mechanisms (2022) (3)
olecular and Cellular Imaging of Atherosclerosis merging Applications (2006) (3)
Fundamental Cardiovascular Research: Returns on Societal Investment: A Scientific Statement From the American Heart Association. (2017) (3)
All manuscripts are not created equal: The expedited publication (1993) (2)
Stromelysin-1 (MMP-3) expression driven by a macrophage-specific promoter results in reduced viability in transgenic mice. (2000) (2)
Arson in the artery: Who set the atheroma aflame? (2019) (2)
Molecular Mechanisms of the Acute Coronary Syndromes (2011) (2)
Examining the dyslipidemia constellation: an interactive forum on new treatment advances. Introduction. (2004) (2)
A Nrf2-OSGIN1&2-HSP70 axis mediates cigarette smoke-induced endothelial detachment: implications for plaque erosion. (2023) (2)
Biology and pathology of atherosclerosis (2010) (2)
Author Correction: Clonal haematopoiesis: connecting ageing and inflammation in cardiovascular disease (2020) (2)
Imaging atherosclerosis: lesion vs. lumen (1996) (2)
Increased myocardial ischemic injury during insulin induced hypoglycemia (1974) (2)
Pravastatin, simvastatin, and atorvastatin appear equally effective for preventing cardiovascular events. (2006) (2)
Atherosclerosis Imaging: A Biological and Clinical Perspective (2009) (2)
REGRESSION OF CORONARY ATHEROMA VOLUME IN PATIENTS RECEIVING HIGH DOSE STATIN THERAPY: ANALYSIS OF THE SATURN STUDY (2012) (2)
Abstract 19592: Coronary Thin-Capped Atheromata Exhibit Increased Expression of Interstitial Collagenases in Regions of Persistently Low Endothelial Shear Stress: A Serial, in vivo Natural History Study in Pigs. (2010) (2)
Novel Lesional Transcriptional Signature Separates Atherosclerosis With and Without Diabetes in Yorkshire Swine and Humans (2021) (2)
Biomarkers associated with coronary high-risk plaques (2022) (2)
Coronavirus Disease 2019 (COVID-19) Coronary Vascular Thrombosis (2022) (2)
ApoA-I Infusion Therapies Following Acute Coronary Syndrome: Past, Present, and Future (2022) (2)
Professor Michael John Davies, MD, FRCPath, FRCP, FACC, FESC July 8, 1937–February 18, 2003 (2003) (2)
Reduction in experimental myocardial infarct size by glucose-insulin-potassium administration☆ (1972) (2)
General cardiologyAbstractsEffect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure (2005) (2)
Human Vascular Smooth Muscle and Endothelial Cells HMG CoA Reductase Inhibitors Reduce Plasminogen Activator Inhibitor-1 Expression (2000) (2)
Abstract 5788: VCAM-1 Targeted PET-CT Detects Inflammatory Atherosclerotic Plaques (2008) (2)
A new opening on aortic stenosis: predicting prognosis with clonal haematopoiesis. (2020) (2)
Comprar Endothelial Dysfunctions in Vascular Disease | Raffaele De Caterina | 9781405122085 | Blackwell Publishing (2007) (2)
0447 AGE AND SEX MODIFY THE ASSOCIATION BETWEEN OSA AND TRADITIONAL AND NOVEL CARDIOVASCULAR RISK FACTORS: THE MULTI-ETHNIC STUDY OF ATHEROSCLEROSIS (MESA) (2017) (2)
Abstract 20401: Cardiorenal Risks of Celecoxib, Naproxen or Ibuprofen in Arthritis Patients : A Sub-Anaylsis From the PRECISION Trial (2017) (2)
Acute pancreatitis with long-term celecoxib vs. ibuprofen or naproxen: data from the PRECISION trial (2018) (2)
Pathophysiology of Atherosclerotic Heart Disease (2003) (2)
Russell Ross 1929–1999 (1999) (2)
Diabetes and vascular diseases. (1997) (2)
Triggers for Inflammation in Atherogenesis Oxidized Lipoproteins and Inflammation (2002) (2)
358Understanding and mitigating the risk of infection with canakinumab (2018) (2)
Residual vascular risk in diabetes - Will the SPPARM alpha concept hold the key? (2019) (2)
Author Correction: A guiding map for inflammation (2020) (2)
Postprandial Hyperglycemia and Risk of Atherosclerosis—Reply (2002) (2)
Abstract 652: ApolipoproteinCIII Induces Expression of Vascular Cell Adhesion Molecule-1 (VCAM-1) in Vascular Endothelial Cells and Increases Adhesion of Monocytic Cells (2006) (2)
2.P.85 Cholesterol-independent effects of pravastatin on atherosclerotic plaque stability in primates (1997) (2)
Visualizing the vascular glue "shearing" the barriers to atherosclerotic plaque imaging. (2010) (2)
Abstract 51: Sortilin 1 Promotes Matrix Vesicle-Mediated Vascular Microcalcification via Rab11 Trafficking and C-Terminal Phosphorylation (2014) (2)
Mechanistic Insights to the Differential Effects of Interleukin-1 Isoforms on Experimental Atherosclerosis (2018) (2)
Endo toxin and Tumor Necrosis Factor Induce Interleukin-1 Gene Expression in Adult Human Vascular Endothelial Cells (2007) (2)
P2683Beneficial effects of red wine intake upon gut microbiota and parallel effects upon plasma metabolomics (2019) (2)
Co-Inhibitory Suppression of T Cell Activation by CD 40 Protects from Obesity and Adipose Tissue Inflammation in Mice Running title : (2014) (2)
Genetically-determined resistance to collagenase action alters content of collagen and smooth muscle cells in atheroma (2002) (1)
Deficiency Attenuates Mouse Abdominal Aortic Aneurysm Formation (2011) (1)
OE-096 Glycated LDL Increases Monocyte CC Chemokine Receptor 2 Expression and Monocyte Chemoattractant Protein-1-Mediated Chemotaxis(Diabetes/Obesity/Metabolic syndrome(01)(H),Oral Presentation(English),The 72nd Annual Scientific Meeting of the Japanese Circulation Society) (2008) (1)
Leaders in Cardiovascular Research: Peter Libby (2019) (1)
Inflammatory Mechanisms of Remodeling in Injured Arteries (1997) (1)
EARLY AND LATE RECURRENT CARDIOVASCULAR RISK IN PATIENTS WITH RECENT ACUTE CORONARY SYNDROME - META-ANALYSIS AND IMPLICATIONS IN TRIAL DESIGN (2021) (1)
Abstract 15575: The Clonal Hematopoiesis Mutation Jak2 V617F Aggravates NETosis and Endothelial Injury in Mouse Arteries With Erosion-like Intimas (2020) (1)
EICOSAPENTAENOIC ACID (EPA) REDUCES INFLAMMATION AND IMPROVES NITRIC OXIDE BIOAVAILABILITY IN PULMONARY ENDOTHELIAL CELLS FOLLOWING EXPOSURE TO AIR POLLUTION PARTICLES (2022) (1)
The functions of blood vessel wall cells in atherogenesis and coronary artery disease. (1989) (1)
Abstract 1945: Low Endothelial Shear Stress (ESS)-Mediated Elastolytic Activity Promotes the Formation of High Risk Atherosclerotic Plaques in the Coronary Arteries (2008) (1)
Chapter 9 – Pathophysiology of Vasculitis (2013) (1)
Abstract 031: A Ligand-specific Blockade of the Integrin Mac-1 Selectively Targets Pathologic Vascular Inflammation While Maintaining Protective Host-defense (2018) (1)
Good Books in Cardiovascular Disease Appearing in 2001 (2002) (1)
Abstract 15355: Interleukin-1beta Inhibition Attenuates Accelerated Atherosclerosis in Mice With Tet2 Loss of Function in a Sex-dependent Fashion (2020) (1)
Swell, or Not Too Swell: Cytokines Regulate Arterial Aneurysm Formation. (2017) (1)
Cardiorenal Risk of Celecoxib compared to Naproxen, or Ibuprofen in Arthritis Patients: Insights from the PRECISION trial. (2022) (1)
Cellular activation in restenosis (1994) (1)
The Metabolic Syndrome and Atherogenesis (2011) (1)
Fish Intake, Contaminants, and Human Health: Evaluating the Risks and the Benefits Part 1 - Health Benefits (2006) (1)
, Mingcan Aneurysms in Mice Induced Abdominal Aortic − Cathepsin K Deficiency Reduces Elastase Perfusion (2011) (1)
Abstract 1724: MRI Enhanced with Magnetic Nanoparticles Measures Inflammatory Burden in Atherosclerosis In Vivo (2006) (1)
Prospective Evaluation of Clinico-Pathological Predictors of Postoperative Atrial Fibrillation (2020) (1)
Segmentation of Anatomical Layers and Artifacts in Intravascular Polarization Sensitive Optical Coherence Tomography Using Attending Physician and Boundary Cardinality Lost Terms (2021) (1)
Matrix Metalloproteinases in Injured Artery (1997) (1)
Plaque Erosion (2019) (1)
Modulating Adaptive Immunity in Vascular Disease: CD4 to the Fore. (2019) (1)
Treatment of normotensive coronary patients with amlodipine or enalapril: Effects on cardiovascular outcomes (2005) (1)
Role of elastolytic cathepsins in vascular remodeling (2004) (1)
EARLY EFFECTSON LOCAL MYOCARDIAL FUNCTION AND THE EXTENT OF MYOCARDIAL NECROSIS (2013) (1)
Extending knowledge of the benefits of statins: The Heart Protection Study. (2002) (1)
Mischief in the marrow: a root of cardiovascular evil. (2022) (1)
Peter Libby, MD: a conversation with the editor. (2012) (1)
Inflammation in Cardiovascular Disease (2006) (1)
Technical Advance Interferon- g -Secreting T-Cell Populations in Rejecting Murine Cardiac Allografts Assessment by Flow Cytometry (1998) (1)
Early and late recurrent cardiovascular events among high‐risk patients with an acute coronary syndrome: Meta‐analysis of phase III studies and implications on trial design (2022) (1)
Expression of thrombospondin-1 (TSP-1) in human cardiac allografts (2000) (1)
Cellular and molecular biology of the cardiovascular system. (1992) (1)
Pathway-Specific Polygenic Risk Scores Identify Obstructive Sleep Apnea–Related Pathways Differentially Moderating Genetic Susceptibility to Coronary Artery Disease (2022) (1)
Expression of the three CXC-chemokines IP-10, MIG and I-TAC by human atheroma-associated cells in vitro and in situ: Implication for lymphocyte recruitment in atherogenesis (1999) (1)
Abstract 5069: Loss of MHC Class II Transactivator Causes Abdominal Aortic Aneurysm (2009) (1)
Abstract 664: Increased Plasma Oxidized Phospholipid:Apolipoprotein B-100 Ratio with Concomitant Depletion of Oxidized Phospholipids from Atherosclerotic Lesions Following Dietary Lipid Lowering: A Potential Biomarker of Early Atherosclerosis Regression (2006) (1)
Eosinophils protect pressure overload- and β-adrenoreceptor agonist-induced cardiac hypertrophy (2022) (1)
A red wine intervention does not modify plasma trimethylamine N-oxide but is associated with broad shifts in the plasma metabolome and gut microbiota composition (2022) (1)
Braunwalds Heart Disease 8Ed One Volume (2007) (1)
Searching for hidden heart risks. (2005) (1)
Monocyte Subset Dynamics in Human Atherosclerosis (2011) (1)
PPAR and cardiovascular risk (2001) (1)
’ Consensus Report The American Journal of Cardiology and Journal of Periodontology Editors ’ Consensus : Periodontitis and Atherosclerotic Cardiovascular Disease (2009) (1)
A ligand-specific blockade of the integrin Mac-1 selectively targets pathologic inflammation while maintaining protective host-defense (2018) (1)
Title EP 4 Receptor ‒ Associated Protein in Macrophages AmelioratesColitis and Colitis-Associated Tumorigenesis (2019) (1)
Libby and King Circulating Biomarkers of Atherothrombotic Disease 2495 large-scale replication study (1)
T 1 Contrast of MPRAGE in Carotid Plaque Imaging (2009) (1)
Reduction in C-Reactive Protein and Low-Density Lipoprotein Cholesterol and Cardiovascular Event Rates After Initiation of Rosuvastatin: A Prospective Study of the justification for the Use of Statins in Prevention: An Intervention, Trial Evaluating Rosuvastatin Trial (2009) (1)
Regulation of smooth muscle profileration in hyperplastic arterial lesions: Research initiatives in vascular surgery * (1989) (1)
Abstract 16242: Anti-Inflammatory Therapy With Canakinumab and Reduction in Total Cardiovascular Events (2018) (1)
A biomarker of inflammation in cardiovascular disease (2003) (1)
In Memoriam: Dr. Akira Yamamoto, 1932-2019 (2019) (1)
Identifying novel mechanisms of abdominal aortic aneurysm via unbiased proteomics and systems biology (2022) (1)
TRAF-1 Deficient Mice Show Impaired Monocyte Recruitment and Decreased Atherogenesis (2008) (1)
3.P.271 Regulated expression of TIMP-3 in human atheroma and lesion-associated cells: A potential protective mechanism for plaque stability (1997) (1)
Association of Interleukin 6 Inhibition With Ziltivekimab and the Neutrophil-Lymphocyte Ratio (2022) (1)
Abstract 3962: TRAF-1 Deficiency Attenuates Atherosclerosis in Mice by Impairing Monocyte Recruitment to the Vessel Wall (2008) (1)
Tu-W24:2 Inflammatory components of the atherosclerotic plaque (2006) (1)
Newly Identified Pro-inflammatory Mechanism of Calcification via Formation of a S100A9-Annexin5 Membrane Complex (2012) (1)
Abstract P295: Oxidative Stress Biomarkers and Incidence of Post-Operative Atrial Fibrillation in the OPERA Trial (2015) (1)
Pathway-specific Polygenic Risk Scores (PRS) identify OSA-related pathways differentially moderating genetic susceptibility to CAD (2021) (0)
Eicosapentaenoic Acid (EPA) Modulates Expression of Inflammatory Proteins in Pulmonary Endothelial Cells following Exposure to Air Pollution Particles (2022) (0)
Allograft Vasculopathy Versus Atherosclerosis Antibody and Complement in Transplant Vasculopathy Interferon- Axis in Graft Arteriosclerosis Vascular Remodeling in Transplant Vasculopathy Chemokines and Transplant Vasculopathy Stem Cells and Transplant Vasculopathy (2007) (0)
In memoriam: Dr. Akira Yamamoto 1932–2019 (2019) (0)
ASSOCIATION OF MRP-8/14 LEVELS AND FUTURE CORONARY EVENTS IN PATIENTS WITH STABLE CAD (2011) (0)
Editorial Board (2009) (0)
Gut intraepithelial T cells calibrate metabolism and accelerate cardiovascular disease (2019) (0)
Multi-object segmentation of anatomical layers in intravascular polarization-sensitive optical coherence tomography using convolutional neural networks (2021) (0)
Abstract: 561 ARTERIAL AND AORTIC VALVE CALCIFICATION ABOLISHED BY ELASTOLYTIC CATHEPSIN S DEFICIENCY IN CHRONIC RENAL DISEASE (2009) (0)
Abstract 15015: Eicosapentaenoic Acid, but Not Docosahexaenoic Acid or a Mixed Omega-3 Fatty Acid Supplement, Inhibits Low-density Lipoprotein Oxidation in a Time-dependent Manner (2020) (0)
Taking Sex Seriously (2020) (0)
JACC: Basic to Translational Science Top Reviewers 2021: With Appreciation (2022) (0)
Coronary Artery Reperfusion (0)
3 D isotropic non-contrast approach for the assessment of carotid arteries stenosis at 3 T (2009) (0)
c-Myb Exacerbates Atherosclerosis Through Regulation of Harmful B2 and Protective IgM-producing Antibody Secreting Cells (2018) (0)
Comprar Braunwalds Heart Disease e-dition Text with Continually Updated Online Reference, Single Volume | Peter Libby | 9781416041047 | Saunders (2007) (0)
Eicosapentaenoic acid reduced levels of angiotensin converting enzyme and caveolin-1 in pulmonary endothelial cells following cytokine treatment (2021) (0)
The European Heart Journal: fulfilling the mission. (2022) (0)
Abstract 8: Oxidized LDL Induces Macrophage Production of Prothrombotic Microparticles (2012) (0)
COMPARING THE EFFECTS OF PHARMACEUTICAL GRADE MINERAL OIL, CORN OIL, EICOSAPENTAENOIC ACID (EPA) AND DOCOSAHEXAENOIC ACID (DHA) IN A MODEL OF ATHEROSCLEROSIS IN VITRO (2023) (0)
Partnerships Promote Translation in Biomedicine (2018) (0)
International Chair/Committee on Cardiometabolic Risk Announced (2006) (0)
Omega-3 fatty acids differentially reduced expression of neutrophil degranulation-associated proteins in endothelial cells during IL-6 exposure (2021) (0)
Abstract: S2-17 CRITICAL ROLE OF MAST CELL CHYMASE IN MOUSE ABDOMINAL AORTIC ANEURYSM FORMATION (2009) (0)
L4 BASELINE CHARACTERISTICS OF PATIENTS IN THE SATURN STUDY, A COMPARISON OF ROSUVASTATIN VERSUS ATORVASTATIN ON CORONARY ATHEROSCLEROTIC DISEASE BURDEN (2010) (0)
DOSE ESCALATION AND THE SAFETY OF CELECOXIB, IBUPROFEN, AND NAPROXEN: ANALYSIS OF THE PRECISION TRIAL (2018) (0)
MECHANISMS OF CARDIAC ALLOGRAFT SURVIVAL WITH BLOCKADE OF CD40-CD40 LIGAND INTERACTIONS (1999) (0)
Swirski to Inflammatory Sites Identification of Splenic Reservoir Monocytes and Their Deployment (2014) (0)
A symposium : new directions in the understanding and management of acute coronary syndromes (2000) (0)
Johann Sebastian Bach. (2019) (0)
Author Correction: Increased prevalence of clonal hematopoiesis of indeterminate potential amongst people living with HIV (2022) (0)
Mac-1 Mediates CD40L-induced Atherogenesis (2007) (0)
Abstract 288: Eosinophil Attenuates Pressure Overload-induced Cardiac Hypertrophy by Releasing Eosinophil Cationic Protein and Interleukin 4 (2019) (0)
Lipoprotein (a) (1991) (0)
Braunwalds Heart Disease e-dition Text with Continually Updated Online Reference, Single Volume (2007) (0)
JACC: Basic to Translational Science Top Reviewers 2022: With Appreciation and Gratitude (2023) (0)
REGULATION OF iNOS EXPRESSION AND MYOCARDIAL CELL DEATH; MECHANISMS OF ALLOGRAFT SURVIVAL WITH CD40 LIGAND DEFICIENCY.: Abstract# 896 Poster Board #‐Session: P153‐III (2000) (0)
Abstract 13401: Prothymosin Alpha (Protα) Associates With Pathogenesis and Sex Predisposition in Rheumatic Heart Valve Disease (2020) (0)
Eicosapentaenoic acid (EPA) reduces pulmonary endothelial dysfunction and inflammation due to changes in protein expression during exposure to particulate matter air pollution. (2023) (0)
Clinical trials report (2002) (0)
981: Eicosapentaenoic Acid Reduces Pulmonary Endothelial Caveolae Protein and Restores Nitric Oxide (2020) (0)
980: Eicosapentaenoic Acid Reduces Pulmonary Endothelial Inflammation Caused by Cytokine Treatment (2020) (0)
1084: EICOSAPENTAENOIC ACID FAVORABLY MODULATES PROTEIN EXPRESSION IN PULMONARY ENDOTHELIAL INFLAMMATION (2021) (0)
Abstract 15700: Targeted Nanoparticle Delivery of a Protein Arginine Deiminase-4 Inhibitor Limits Arterial Intimal Netosis and Preserves Endothelial Integrity in Mouse Arterial Erosion-like Injury (2020) (0)
Results Deficiency of Recipient Mac-1 Attenuates PR and Prolongs Graft Survival in Total Allomismatched Allografts (2008) (0)
on Serum Cholesterol Statins Reduce Inflammation in Atheroma of Nonhuman Primates Independent of Effects (2002) (0)
Eicosapentaenoic Acid Improves Endothelial Nitric Oxide Bioavailability and Changes Fatty Acid Content in a Manner Distinct from Docosahexaenoic Acid (2021) (0)
Allan Shor Infection ? Chlamydia pneumoniae Atherosclerosis : Lipid Infiltration or (2002) (0)
The future of living well to 100 1-3 (2006) (0)
Intra-vital microscopy of haematopoietic progenitor cells in the bone marrow (2015) (0)
Transplantation Loss of Myeloid Related Protein-8 / 14 Exacerbates Cardiac Allograft Rejection (2011) (0)
Peter Libby Current Concepts of the Pathogenesis of the Acute Coronary Syndromes (2001) (0)
143 A role for interferon-γ but not interleukin-4 in graft arteriosclerosis (1997) (0)
Abstract 1514: CC Chemokine Receptor-1 (CCR-1) Recruits Host-Derived Intimal Smooth Muscle-like Cell in Graft Arterial Disease (2006) (0)
Neutrophil-lymphocyte ratio predicts cardiovascular events in people with type 2 diabetes: post hoc analysis of the SUSTAIN 6 and PIONEER 6 cardiovascular outcomes trials. (2023) (0)
Abdominal Aortic Aneurysms : Pathophysiological Mechanisms and Clinical Implications Series (2006) (0)
Abstract 329: Systems-based Target Discovery Reveals PPARa as a Key Metabolic Regulator for Macrophage Activation in Vein Graft Disease (2018) (0)
The Heart in COVID-19 (2020) (0)
Schönbeck and Libby CD 40 / CD 40 L and Atherosclerosis (2001) (0)
Abstract 1650: ApolipoproteinCIII induces THP-1 Cell Adhesion to Endothelial Cells via Pertussis Toxin-Sensitive G-Protein- and Protein Kinase C{alpha}-Mediated Nuclear Factor-{kappa}B Activation (2006) (0)
Eicosapentaenoic acid inhibits lipopolysaccharide (LPS)-induced nitrite production and cytokine release from J774 macrophages (2021) (0)
Cholesterol-independent effect of statins on the atherosclerotic lesions stability in primates (2000) (0)
EARLY ATHEROPROTECTION THROUGH SYK INHIBITION FAILS IN ESTABLISHED DISEASE WHEN PLAQUE MACROPHAGES PROLIFERATE (2016) (0)
A second term for the editors. Status and goals for the review process. (1996) (0)
Early atheroprotection by SYK inhibition fails in established disease when local macrophage proliferation dominates lesion progression (2016) (0)
Usefulness of Tachycardic-Stress Perfusion Imaging to Predict Coronary Artery Disease in High-Risk Patients With Chronic Renal Failure (2003) (0)
Clinical trials report (2003) (0)
Abstract 2989: Risk of Stroke After Acute Coronary Syndromes In The MIRACL Study Related to Baseline Inflammatory Markers (2006) (0)
Preface to the Ninth Edition (2012) (0)
Eicosapentaenoic acid reduces cytokine-induced expression of multiple proteins related to platelet activation and aggregation in pulmonary and vascular endothelium (2021) (0)
TH2 CYTOKINE PROFILE MODULATION BY INTERLEUKIN-10 ADMINISTRATION AUGMENTS GRAFT ARTERIAL DISEASE IN MURINE HEART ALLOGRAFTS. (1999) (0)
EICOSAPENTAENOIC ACID (EPA) COMBINED WITH HIGH INTENSITY STATINS REDUCE LIPID OXIDATION IN MODEL MEMBRANES (2022) (0)
Expression in Human Endothelial Cells Activators Inhibit Cytokine-Induced Vascular Cell Adhesion Molecule-1 α PPAR (1999) (0)
Abstract 5764: Molecular Imaging Tracking Phagocytosis and Protease Activity Reports on Cardiac Allograft Rejection (2008) (0)
Induction of Endothelial-Leukocyte Interaction by Interferon-&ggr; Requires Coactivation of Nuclear Factor-&kgr;B (2001) (0)
Coronary Flow Reserve, Inflammation and Myocardial Strain in the Cardiovascular Inflammation Reduction Trial (CIRT-CFR) (2022) (0)
Interleukin-1 Beta as a Target for Atherosclerosis Therapy Biological CANTOS (0)
EICOSAPENTAENOIC ACID (EPA) DECREASES ANGIOTENSIN CONVERTING ENZYME (ACE) EXPRESSION IN VASCULAR AND PULMONARY ENDOTHELIUM FOLLOWING CYTOKINE CHALLENGE (2022) (0)
This information is current as Mice lprFas Lupus Erythematosus-like Manifestations in Cathepsin K Deficiency Ameliorates Systemic (2017) (0)
Comparative Effects of Mineral Oil, Corn Oil, Eicosapentaenoic Acid, and Docosahexaenoic Acid in an In Vitro Atherosclerosis Model (2023) (0)
THE EFFECT OF HIGH–INTENSITY STATIN THERAPY ON CHANGES IN ATHEROMA COMPOSITION: INSIGHTS FROM SATURN (2013) (0)
Abstract 1124: CD40L Induces Inflammation in Adipose Tissue - a Potential Link Between the Metabolic Syndrome and Atherosclerosis (2007) (0)
An activatable MR imaging agent reports myeloperoxidase activity in healing infarcts and detects the anti-inflammatory effects of atorvastatin on ischemia- reperfusion injury non-invasively (2009) (0)
Deficiency of EP4 receptor on bone marrowderived cells boosted inflammation and abdominal aortic aneurysm formation induced by angiotensin II in hyperlipidemic mice (2010) (0)
ATVB In Focus Abdominal Aortic Aneurysms: Pathophysiological Mechanisms and Clinical Implications (2006) (0)
What Do the Newer Trials Tell Us About the Treatment of Coronary Heart Disease (2020) (0)
REGRESSION OF CORONARY ATHEROSCLEROSIS IN DIABETIC PATIENTS WITH HIGH INTESITY STATIN REGIMENS: INSIGHTS FROM SATURN (2013) (0)
1081: EICOSAPENTAENOIC ACID REDUCES PULMONARY ENDOTHELIAL CELL ADHESION PROTEIN EXPRESSION WITH IL-6 (2021) (0)
Non-coronary atherosclerosis : additional costs according to involvement of vascular beds (2017) (0)
Omega-3 fatty acids differentially alter the expression of detoxification enzymes and nitric oxide bioavailability in endothelial cells during IL-6 exposure (2021) (0)
Tumor Necrosis Factor Receptor p55 and p75 Double Deficiency on Donor Hearts Diminishes Graft Arterial Diseases (2002) (0)
Mischief in the marrow: a root of cardiovascular evil. (2022) (0)
Editors’ Preamble to The Journal of Cardiovascular Aging (2021) (0)
Localization of prostaglandin synthase in human and ovine placental membranes (1989) (0)
Abstract 15887: Clonal Hematopoiesis Links Premature Menopause to Cardiovascular Disease (2020) (0)
Loss of MRP-14 Augments Costimulatory molecule Expression and Exacerbates Cardiac Allograft Rejection (145.47) (2010) (0)
Roles of Vascular Cells in Inflammation and Immunopathology (1991) (0)
Gaps in beliefs and practice in dyslipidaemia management in Japan, Germany, Colombia and the Philippines: insights from a web-based physician survey (2020) (0)
Abstract 11627: Eosinophil Attenuates Cardiac Hypertrophy, Apoptosis and Fibrosis by Releasing Eosinophil Cationic Protein and Il-4 (2018) (0)
Monocyte heterogeneity in cardiovascular disease (2013) (0)
Eicosapentaenoic Acid Increases Vascular and Pulmonary Endothelial Ferritin Levels with Enhanced Heme Oxygenase-1 Expression during Inflammation (2022) (0)
P5421Cardiorenal risk of celecoxib compared to naproxen, or ibuprofen in arthritis patients: a sub-analysis of the PRECISION trial (2018) (0)
PHARMACEUTICAL GRADE MINERAL OIL AND CORN OIL DO NOT INFLUENCE PHOSPHOLIPID MEMBRANE OXIDATION RATES COMPARED TO OMEGA-3 FATTY ACIDS IN VITRO (2023) (0)
Impact of Abdominal Obesity on CVD and Diabetes (2013) (0)
Rebuttal from Daniel Beard and (2013) (0)
Abstract 14692: Loss of Myeloid Related Protein (MRP)-8/14 Augments B7 molecule Expression and Exacerbates Cardiac Allograft Rejection (2010) (0)
LIBBY , MAROKO , BRAUNWALD the intravenous administration of 2 units / kg crystalline zinc insulin (2005) (0)
Contents of Volume 74 (2000) (2000) (0)
EXPRESSION OF THROMBOSPONDIN AND RECEPTORS IN HUMAN CARDIAC ALLOGRAFTS AND ITS DIFFERENTIAL REGULATION IN EC AND SMC BY CYTOKINES.: Abstract# 41 (2000) (0)
Braunwald's Heart Disease Online (2007) (0)
1SY02-5 Inflammatory activators in the acute coronary syndromes (2003) (0)
EICOSAPENTAENOIC ACID (EPA) REDUCES J774 MACROPHAGE ACTIVATION AND CYCLOOXYGENASE (COX-1) EXPRESSION (2022) (0)
as a Potential Mediator in Vascular Disease γ Type-1 Expression : PPAR Activation in Human Endothelial Cells Increases Plasminogen Activator Inhibitor γ PPAR (1999) (0)
THE ROLE OF INFLAMMATION IN ATHEROGENESIS AND IN GUIDING THERAPY OF ATHEROSCLEROSIS (2003) (0)
Coronary plaque characteristics associated with major adverse cardiovascular events in atherosclerotic patients and lesions – a systematic review and meta-analysis (2022) (0)
CD134 Ligand Deficiency Diminishes Graft Arterial Diseases in Murine Cardiac Allocarafts (2002) (0)
Interleukin-1 (IL-1) activates adult human vascular smooth muscle cells (SMC) (1987) (0)
The Molecular Mechanisms of the Acute Coronary Syndromes(The 71st Annual Scientific Meeting of the Japanese Circulation Society) (2007) (0)
Statins in the Management of LDL-C (2013) (0)
Abstract 15990: Macrophage Migration Inhibitory Factor Directly Influences Aortic Aneurysm Development in a Murine Model (2011) (0)
Increased prevalence of clonal hematopoiesis of indeterminate potential amongst people living with HIV (2022) (0)
Cholesterol accumulation in macrophages drives NETosis in atherosclerotic plaques via IL-1β secretion (2022) (0)
Abstract 45: Sortilin Regulates Arterial Calcification in Atherosclerotic Mice and Associates With Cardiovascular Risk in Humans (2016) (0)
Abstract 16218: Long-Term Anti-Atherosclerotic Effects of Maximally Intensive Statin Therapy Following Acute Coronary Syndrome: Insights From SATURN (2013) (0)
Abstract 318: Eicosapentaenoic Acid Improved Nitric Oxide Bioavailability and Reduced Nitroxidative Stress in Human Endothelial Cells in Contrast to Arachidonic Acid In Vitro (2020) (0)
Abstract 1723: In vivo Imaging of Anti-Atherosclerotic Pharmacotherapy with a VCAM-1 Targeted Multimodal Nanoparticle (2006) (0)
Flow Perturbation Mediates Neutrophil Recruitment and Potentiates Endothelial Injury via TLR2 in MiceNovelty and Significance (2017) (0)
Distinct CSF1 Micro-Environments Maintain Monocytes within a Perivascular Bone Marrow Niche (2020) (0)
Th-W56:5 MMP-10 (stromelysin-2): New biomarker for clinical and subclinical atherosclerosis (2006) (0)
Author Correction: B lymphocyte-derived acetylcholine limits steady-state and emergency hematopoiesis (2022) (0)
Abstract: 64 LYSYL-OXIDASE-DEPENDED EXTRACELLULAR MATURATION OF COLLAGEN IS REDUCED IN HYPERINFLAMED ATHEROSCLEROTIC PLAQUES OF APOE−/− MICE (2009) (0)
Inflammatory Biomarkers Update: Overview of Recent Research (2007) (0)
Effects ofAcuteCellular Injury on Coronary Vascular Reactivity inAwakeDogs (1978) (0)
959: Eicosapentaenoic Acid Inhibits ICAM-1 Expression in Pulmonary Endothelial Cells With Inflammation (2020) (0)
Abstract 17472: Interruption of Classic CD40L-CD40 Signaling But Not of the Novel CC40L-Mac-1 Interaction Limits Arterial Neointima Formation in Mice (2012) (0)
Infections and Vascular Disease (2007) (0)
Accumulation in Atherosclerotic Plaques Genetically Determined Resistance to Collagenase Action Augments Interstitial Collagen (2013) (0)
IS023 Antisense Proliferating-cell Nuclear Antigen Oligonucleotide Attenuates Cardiac Allograft Arteriopathy (2000) (0)
n g l a d r n a l of m e d i c i n e Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease (2017) (0)
Abstract WP229: Eicosapentaenoic Acid (EPA) Modulates Expression Of Thrombotic And Metabolic Proteins In Brain Endothelium Following Cytokine Challenge (2022) (0)
Abstract 11636: Critical Roles of Mast Cells in Streptozotocin-Induced Diabetic Cardiomyopathy (2018) (0)
Reports from the 81st EAS Congress (2013) (0)
Braunwalds Heart Disease 8Ed. 2 Volume Set (2007) (0)
Kruppel-like Factor KLF10 Targets Transforming Growth Factor-1 to Regulate CD4CD25 T Cells (2009) (0)
EICOSAPENTAENOIC ACID (EPA) INCREASES HEME OXYGENASE-1 EXPRESSION IN MACROPHAGES AND ENDOTHELIAL CELLS DURING INFLAMMATION (2022) (0)
7 Cytokines in atherogenesis (1997) (0)
Abstract 20832: Neutrophil Extracellular Traps Increase Endothelial Activation and Thrombogenicity via IL-1α and NF-κB: Implications for Superficial Erosion (2017) (0)
Reply: The Networks Between the Sympathetic Nervous System and Immune System in Atherosclerosis. (2016) (0)
This information is current as Pathological Findings in Mice like Autoimmunity and − Erythematosus CD 74 Deficiency Mitigates Systemic Lupus (2017) (0)
Pathophysicology of the Atheroma and Mechanisms of Plaque Rupture (2000) (0)
The Macrophage and Atherosclerotic Process (2000) (0)
Introduction of international research facilities: Brigham and Women's Hospital (2008) (0)
Obligate role of macrophage colony-stimulating factor for the development of neointimal thickening following arterial injury (2003) (0)
Abstract: 1048 THE “UNSTABLE” ATHEROSCLEROTIC PLAQUE (2009) (0)
IS051 MOLECULAR REGULATION OF APOPTOSIS OF VASCULAR CELLS DURING THE PATHOGENESIS OF ATHEROSCLEROSIS (1997) (0)
Group 2 innate lymphoid cells protect mouse heart from myocardial infarction injury via interleukin 5, eosinophils, and dendritic cells (2022) (0)
Abstract 13288: An Oral Inhibitor Of Matrix Metalloproteinase 13 (MMP-13) Increases Collagen Content Of Mouse Atheromata (2010) (0)
379: Eicosapentaenoic Acid Preserves Pulmonary Endothelial Nitric Oxide Release Following LPS Challenge (2020) (0)
Does inflammation link many diseases (2018) (0)
Flow perturbation mediates neutrophil recruitment and potentiates endothelial injury via TLR2 in mice. A novel in vivo approach for probing the pathophysiology of superficial erosion (2016) (0)
EFFECTS OF SERUM FROM PATIENTS WITH KAWASAKI DISEASE ON CULTURED ARTERIAL ENDOTHELIAL AND SMOOTH MUSCLE CELLS (1984) (0)
Libby Gaps Between Mouse Experiments and Human Disease 923 The Hygiene Hypothesis and the Microbiome as a Barrier to Translatability of Laboratory Experiments in Mice to Those in Humans (0)
Abstract 11595: Characterization of Human Coronary Atherosclerosis Using Polarization-Sensitive Optical Frequency Domain Imaging (2017) (0)
1082: EICOSAPENTAENOIC ACID INCREASES ENDOTHELIAL FUNCTION AND HEME OXYGENASE-1 IN PULMONARY INFLAMMATION (2021) (0)
Early intervention with atorvastatin modulates Th1/Th2 imbalance in patients with acute coronary syndrome : From bedside to bench - Response (2004) (0)
Claudio Vinegoni Lipid-Rich , Inflamed Atherosclerotic Plaques Indocyanine Green Enables Near-Infrared Fluorescence Imaging of (2011) (0)
IS034 Dietary Consumption of Tea Catechin Attenuates Hyperlipidemia-induced Atherosclerosis (2000) (0)
, Chronic Renal Disease Arterial and Aortic Valve Calcification Abolished by Elastolytic Cathepsin S Deficiency in (2009) (0)
Comprar Braunwalds Heart Disease 8Ed One Volume | Robert O. Bonow | 9781416041061 | Saunders (2007) (0)
4P-1088 Characterization of a new EP4 receptor-associated protein that plays a pivotal role in PGE2-mediated anti-inflammation (2003) (0)
Gender Differences in Postprandial Endothelial Function (2001) (0)
819 Internalization of CXCR3 on activated T cells following contact with IFNg-activated human endothelial cells: Differential effects of I-TAC, Mig, and I-TAC (2000) (0)
ACHIEVED LIPOPROTEIN LEVELS AND REGRESSION OF CORONARY ATHEROSCLEROSIS WITH HIGH DOSE STATIN THERAPY: INSIGHTS FROM SATURN (2012) (0)
chapter 6 – Atherosclerosis (2006) (0)
Abstract WP210: Eicosapentaenoic Acid (EPA) Decreases Cytokine Release And Inflammatory Proteins In Brain Vascular Endothelium During Inflammation (2022) (0)
RED WINE REMODELS GUT MICROBIOTA INDEPENDENTLY OF TRIMETHYLAMINE N-OXIDE LEVELS (2022) (0)
Inflammation and Immunity : A Common Pathway in the Pathogenesis of Diseases That Affect All Levels of the Arterial Tree (2015) (0)
Rabbit Models of Atherosclerosis Masanori Aikawa, Yoshihiro Fukumoto, (2000) (0)
Guidelines for valvular heart disease (2007) (0)
Abstract: 611 MACROPHAGE IMAGING IN GRAFT REJECTION (2009) (0)
Vascular matrix metalloproteinases (MMP) may contribute to destabilization of atherosclerotic plaques (1994) (0)
Remembering Dr. James T. Willerson (2020) (0)
Abstract 1725: Statin Therapy Reduces Cysteine Protease Activity in Atherosclerosis in vivo (2006) (0)
Report from the Scientific Poster Session at the 13th Annual Cardiometabolic Health Congress in Boston, USA, 24–27 October 2018 (2018) (0)
Abstract 12053: Traf2 Does Not Modulate Atherogenesis in Mice and is Not Associated With Atherosclerosis in Humans (2010) (0)
Mitogenic effect of interleukin 1 il 1 on vascular smooth muscle cells smc possible inhibition by endogenous prostanoids induced by il 1 (1987) (0)
Treatment of Endothelial Dysfunction and Atherosclerosis by Cholesterol Lowering (2007) (0)
Postprandial hyperglycemia and risk of atherosclerosis. Authors' reply (2002) (0)
Systems Approach Identified PPARα as a Therapeutic Target for Vein Graft Disease: the Effects of the Specific Activator Pemafibrate on Macrophage Activation (2018) (0)
Molecular Mechanisms of the Arterial Wall in Acute Coronary Syndromes (2018) (0)
Abstract 2259: Risk of Death and Beneficial Effects of Statins in Acute Coronary Syndromes Related to Inflammatory Markers in the MIRACL Study (2006) (0)
963-19 Evidence for Complement Activation by Smooth Muscle Cells in Lesions of Advanced Pulmonary Hypertension (PH) (1995) (0)
Potential of Osteoclasts in Calci fi ed Human Aortic Valves (2017) (0)
Abstract 11578: Genome-Wide Pleiotropy Analysis of Coronary Artery Disease and Pneumonia (2021) (0)
Cardiovascular Burden of COVID-19 and the Post-Covid Era (2021) (0)
MYOCARDITIS AND FEVERS: TICKING OFF THE LIST OF POSSIBILITIES (2019) (0)
Mechanisms Underlying Instability of Atherosclerotic Plaques (1996) (0)
Biologically-Based Therapies for Aortic€Diseases (2018) (0)
Which is More Important: Plaque Quantity or Plaque Rupture? (2020) (0)
Corrigendum to “Adiponectin inhibits macrophage tissue factor, a key trigger of thrombosis in disrupted atherosclerotic plaques” [Atherosclerosis 226 (2) (2013) 373–377] (2013) (0)
Human vascular smooth muscle cells express an endogenous inhibitor of Caspase-1 (2000) (0)
Abdominal Aortic Aneurysms : Pathophysiological Mechanisms and Clinical Implications (2006) (0)
Focus Seminar: Historical & Conceptual Changes of Coronary Artery Disease (1980–2020) From Focal Lipid Storage to Systemic Inflammation (2019) (0)
Statin drugs might boost healthy gut microbes (2020) (0)
Eicosapentaenoic acid modulates endothelial function and inflammatory protein expression from pulmonary and vascular tissues following cytokine challenge (2021) (0)
Featuring: Dr Peter Libby. (2017) (0)
0SOA02-1 What is happening inside an atherosclerotic plaque? (2003) (0)
Abstract 1483: The Role of Genetically Programmed Biases in Th1 and Th2 Immune Responses in Atherogenesis (2006) (0)
Arteriosclerosis Transplantation But Does Not Prevent Graft Donor-Specific Tolerance in Mouse Cardiac Long-Term Allograft Survival and Host CD 40 Ligand Deficiency Induces (2000) (0)
Chemokines, monocytes, T cells, and the adaptive immune response in atherosclerosis (2000) (0)
ACUTELY REJECTED MURINE CARDIAC ALLOGRAFTS IN IFN-γ DEFICIENT RECIPIENTS SHOW INCREASED MACROPHAGE INFILTRATION, ELEVATED MIP-2, AND MARKEDLY DECREASED RANTES EXPRESSION (1999) (0)
Abstract 1732: Specific In Vivo Imaging of Macrophages in Atherosclerosis With a Targeted Multimodal Magnetofluorescent Nanoparticle (2006) (0)
Clonal Hematopoiesis at Crossroads of Aging, Cardiovascular Diseases, and Cancer: JACC Topic of the Week (2019) (0)
Is ACE Inhibition the Standard of Care for Management of Coronary Artery Disease (2000) (0)
The effect of ziltivekimab on the neutrophil-lymphocyte ratio: analysis from RESCUE (2022) (0)
Adhesion molecules in intimal monocyte-macrophage recruitment (1994) (0)
Abstract 14380: The Effect of Canakinumab on the Rates of Non-ST-Segment Elevation and ST-Segment Elevation Myocardial Infarctions (2018) (0)
CC Chemokine Receptor-1 Activates Intimal Smooth Muscle–Like Cells in Graft Arterial Disease Molecular Cardiology (2009) (0)
Leaders in cardiovascular medicine today (2016) (0)
Inflammation and Atherosclerosis Clinical Cardiology: New Frontiers (2002) (0)
Abstract: 1071 PLASMA PENTRAXIN 3 LEVELS REFLECT METABOLIC SYNDROME IN PATIENTS WITH CORONARY ARTERY DISEASE (2009) (0)
Experimental Myocardial Infarction in Mice Matrix Metalloproteinase Inhibition Attenuates Early Left Ventricular Enlargement After (1999) (0)
Abstract 5104: Enhanced Expression of Tumor Necrosis Factor Receptor-Associated Factors in Acute and Chronic Coronary Heart Disease Correlates with Circulating Inflammatory Markers (2008) (0)
The Macrophage and The Atherosclerotic Process (2003) (0)
Coronary Flow Reserve, Inflammation, and Myocardial Strain (2022) (0)
Abstract 3689: Loss of Myeloid Related Protein-8/14 Exacerbates Cardiac Allograft Rejection (2008) (0)
Eicosapentaenoic acid Reduces Expression of Pulmonary Endothelial Angiotensin Converting Enzyme (ACE) Linked to Inflammation (2021) (0)
Interrelation between atherosclerosis and restenosis. (1995) (0)
Abstract 758: Adiponectin Reduces T Lymphocyte Accumulation in Atherosclerotic Lesions by Inhibiting T Lymphocytotropic CXC Chemokines (2007) (0)
Exercise reduces inflammatory cell production and cardiovascular inflammation via instruction of hematopoietic progenitor cells (2019) (0)
Differential IL18 signaling via IL18 receptor and Na-Cl co-transporter discriminating thermogenesis and glucose metabolism regulation (2022) (0)
Author Correction: Increased prevalence of clonal hematopoiesis of indeterminate potential amongst people living with HIV (2022) (0)
Why Y? The Y chromosome may serve a cardiovascular purpose after all. (2023) (0)
Abstract 13340: Crp Lowering with High-Intensity Statin Therapy Associates with Regression of Coronary Atherosclerosis and Improved Clinical Outcomes: Insights from Saturn (2012) (0)
EICOSAPENTAENOIC ACID (EPA) MODULATED EXPRESSION OF PROTEINS LINKED TO PLATELET ACTIVATION AND THROMBOSIS IN VASCULAR ENDOTHELIAL CELLS DURING INFLAMMATION (2023) (0)
The Biochemical Basis of Atherosclerosis: Roles for Cytokines (1991) (0)
Atherosclerosis Progression and Vascular Adaptation (1997) (0)
Abstract 5570: TRAF5 Deficiency Accelerates Atherogenesis in Mice: A Role for TRAF5 as Protective Factor in Atherosclerosis? (2009) (0)
THE VESSEL WALL AS A SOURCE OF VASORHGOLATORY AND IMMDNOSTIMOLATORY CYTOKINES (1987) (0)
Biologically-Based Therapies for Aortic Diseases: Why the Long Lag in Translation? (2018) (0)
INCREASED EXPRESSION OF ATP-CITRATE LYASE (ACLY) AND RELATED METABOLIC PROTEINS IN ENDOTHELIAL CELLS DURING INFLAMMATION (2023) (0)
Contribution of IFN-γ to acute allograft failure in murine cardiac transplants: Role in vascular thrombosis (1998) (0)
Interaction of CD40L with the Leukocyte Integrin Mac-1: A New Pathway for CD40L-Mediated Inflammation in Atherogenesis (2008) (0)
Libby and King Circulating Biomarkers of Atherothrombotic Disease 3 Use of Biomarkers in Clinical Practice (0)
Integrative Ly-6C high Monocytes Depend on Nr4a1 to Balance Both Inflammatory and Reparative Phases in the Infarcted Myocardium (2014) (0)
Stabilization of Mast Cells for Taming Vulnerable Plaques (2012) (0)
Clonal Hematopoiesis and Cardiac Transplantation: The Intersection of Inflammation and Arteriopathy? (2023) (0)
Comprar Braunwalds Heart Disease 8Ed. 2 Volume Set | Robert O. Bonow | 9781416041078 | Saunders (2007) (0)
Group 2 Innate Lymphoid Cells Protect Mice from Abdominal Aortic Aneurysm Formation via IL5 and Eosinophils (2023) (0)
Abstract 2904: Interleukin-18, the Metabolic Syndrome, and Subclinical Atherosclerosis: Results from the Dallas Heart Study (2006) (0)
Triggers for Inflammation in Atherogenesis Oxidized Lipoproteins (2002) (0)
3.C.3 Mechanisms of disruption of the atheromatous plaque (1997) (0)
Soluble vascular cell adhesion molecule-1 (sVCAM-1) and intercellular adhesion molecule-1 (sICAM-1) correlates with carotid thickness (1998) (0)
Abstract 18687: PARP9 and PARP14 are Novel Regulators of Macrophage Activation (2014) (0)
19 Cholesterol-lowering independent effects of pravastatin on the artery wall of atherosclerotic primates (1997) (0)
Myocardial infarction accelerates (2012) (0)
Abstract 13147: Obstructive Sleep Apnea Associates With Elevated Leukocytes and Markers of Inflammation in the Multi-Ethnic Study of Atherosclerosis (MESA) (2016) (0)
Vitamin D in atherosclerosis and cardiovascular events. (2023) (0)
Immunotherapy with an agonistic anti-CD40 antibody limits adipose tissue inflammation and protects from pre-established metabolic disease in mice (2013) (0)
Extracellular Matrix Digestion (2005) (0)
CD40 and CD40L (CD154) (2002) (0)
Molecular Imaging in Cardiovascular Disease (2012) (0)
143 A pivotal role for NRF2 in endothelial detachment–implications for endothelial erosion of stenotic plaques (2019) (0)
Genetic modification of inflammation and clonal hematopoiesis-associated coronary artery disease (2022) (0)
SOTAGLIFLOZIN, A DUAL SGLT 1 AND 2 INHIBITOR, MODULATED EXPRESSION OF ATHEROPROTECTIVE PROTEINS DURING INFLAMMATION COMPARED WITH EMPAGLIFLOZIN (2023) (0)
Inhibition the Standard of Care for Management of Coronary Artery Disease ? (2002) (0)
HEART TRANSPLANTATION USING MICE LACKING B7-1 AND B7-2 DEMONSTRATES THAT GRAFT SURVIVAL IS DETERMINED BY EXPRESSION OF B7 MOLECULES ON RECIPIENT, NOT DONOR CELLS. (1999) (0)
Abstract 9018: Serial in vivo Imaging Reveals a Key Function for Splenic Monocytes in Infarct Healing (2011) (0)
Overview of the biologic determinants of plaque instability (2000) (0)
Results Obese Wild-Type Mice Exhibit Higher CXCR 3 Expression in Periepididymal AT Than Lean Wild-Type Mice (0)
Abstract 1735: Adiponectin, an Anti-Inflammatory Adipocytokine, Regulates T Lymphocytes Recruitment by Inhibiting T Lymphocytotropic CXC Chemokines in LPS-Stimulated Macrophages: A Potential Anti-Atherogenic Function of Adiponectin (2006) (0)
Are we victims of our own success in cardiovascular therapeutics? (2007) (0)

This paper list is powered by the following services:

Other Resources About Peter Libby

en.wikipedia.org